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Abstract
Optical coherence microscopy (OCM) combines optical coherence tomography (OCT) with
confocal microscopy and enables depth resolved visualization of biological specimens with
cellular resolution. OCM offers a suitable alternative to confocal imaging by providing enhanced
contrast due to the additional coherence gate to the inherent confocal gate, increasing the field
of view and imaging depth, and eliminating the need of external contrast agents. In the past,
development of OCT systems have been focused on time domain and spectral/Fourier domain
methods which offer high axial resolution and imaging speeds. However, recent advances in the
OCT technology have pushed the development into the direction of swept source OCT
technologies, and development of the OCM technology is likely to follow this path.
This thesis describes construction, characterization and preliminary imaging results of a swept
source OCM (SS-OCM) system utilizing a novel light source, Vertical Cavity Surface-Emission
Laser (VCSEL). This swept source laser can reach sweep rates exceeding 1 MHz and provide
wide tuning ranges, which will enable both imaging speeds approaching to time domain OCM
(TD-OCM) systems, and axial resolution approaching to spectral/Fourier domain OCM (SD-OCM)
systems. Several other advantages of SS-OCM compared to TD-OCM and SD-OCM that make
this technology a promising alternative to the latter imaging methods are presented.
Furthermore, practical concepts in the system development and signal processing, such as
compensation for the scan curvatures, methods for calibration of the spectrums, selection of
suitable color maps for display, and other related topics are also discussed in the text.
In addition to technical description of the OCM system development, an in depth analysis of
several clinical applications that will be likely to benefit from this imaging modality is also
presented. Real time intraoperative feedback is required in order to reduce the morbidity and
the rate of additional operations for the surgical management of several forms of cancer, where
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a benchtop OCM system residing in the pathology laboratory can be immensely beneficial.
Furthermore, with the novel scanning mechanisms that have been developed in the recent
years it is possible to translate this imaging modality to an in vivo setting where an OCM probe
can be inserted through the working channel of an endoscope and generate cellular resolution
images in real time without the need of external contrast agents. Endoscopic management and
clinical challenges for a spectrum of lower gastrointestinal (GI) diseases is discussed where an in
vivo OCM imaging probe can play an important role in the diagnosis and evaluation of the
extend of the particular disease. A review of alternative imaging modalities, such as
chromoendoscopy, narrow band imaging (NBI) and confocal laser endomicroscopy (CLE) is also
included which outlines the relative strengths and limitations of these imaging modalities for
the clinical management of lower GI diseases.
Thesis Supervisor: James G. Fujimoto
Title: Elihu Thomson Professor of Electrical Engineering
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1. Introduction and Scope of the Thesis
There are several cancer imaging applications that will benefit from an imaging modality that
provides non-destructive evaluation of pathological state of the tissue in real time. The
following discussion will provide insight on some of the pressing challenges for the
management of breast, lung, head and neck, and thyroid cancers, where real time
intraoperative feedback is required in order to reduce the morbidity and the rate additional
operations for the surgical management of the particular disease.
For the clinical management of non-metastatic breast cancer, breast conserving therapy
(BCT) is the standard of care for the surgical intervention due to its superiority over radical
mastectomy in terms of providing acceptable cosmetic outcome, reduced morbidity associated
with lymphedema, and improved quality of life after operation, as well as ensuring equivalence
in the survival and low rate of local recurrence [1-4]. Although in order to provide best cosmetic
outcome it is important to resect only the tissue involved in the cancer, this approach often
leads to residual tumor tissue at the boundaries of the excised specimen or the lumpectomy
cavity, especially for the case of clinically occult (nonpalpable) lesions [5, 6]. Consequently, up
to 40% of all patients undergoing BCT require repeat surgical resection as a result of positive or
close margins [7-11]. Alternative real time imaging strategies such as frozen section analysis
(FSA) suffers from sampling errors, low sensitivity (~70%) and increased procedure time (>15
minutes), and are often destructive for small specimens [12-15].
For the surgical management of lung cancer, which accounts for 28% of all cancer related
deaths, early detection of smaller sized tumors is increased over the past years owing to the
advancements on radiological imaging techniques [16-18]. Although the safe way for the
management of a confirmed lung malignancy is a pulmonary lobectomy, which involves the
surgical removal of the lobe involved with the cancer, improvements in the detection of lower
grade tumors has pushed the applications of lung sparing surgeries such as wedge resection
and sleeve resection [19-21]. With the studies showing equivalence of survival rates to standard
lobectomy, lung sparing procedures have the potential to provide the removal of the tumor
without compromising the lung function [22]. For these surgeries it is important to ensure a
tumor free margin in order to minimize recurrence. Although gross evaluation and image
guidance is routinely being used for discriminating the overall boundaries of the tumor, studies
have shown that about 31% of the central tumors and 19% of the peripheral tumors have a
microscopic proximal extension, making it hard to detect with these methods [23, 24].
Consequently up to 17% of resection cases shows a positive bronchial margin at the resection
boundary [25]. The application of FSA for intraoperative margin assessment during the lung
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resection surgery suffers from low sensitivity as it is shown to have about 42% false negative
rate in detecting the presence of tumor cells at the resection margin [26].
Another challenge for the management of lung cancer is to establish a correct diagnosis
on suspicious lung nodules. As an example, studies have found a thoracic metastasis in up to
18% of breast cancer patients, hence for the patients with a history of breast cancer it is critical
to distinguish between breast cancer metastasis and primary lung lesion, as the surgical
management for these two scenarios are vastly different [27, 28]. Even with bronchoscopic
guidance, transbronchial biopsy suffers from sampling problems and low yield [29, 30]. FSA has
been used to provide an intraoperative diagnosis for the suspicious lung nodules, however, it
has shown to have a 7.5% error rate for detecting malignancy [31]. Furthermore, another study
showed deferral to permanent histology with a rate of 15.5% in making a differential diagnosis
between primary lung lesion and metastatic breast carcinoma, showing the limitation of FSA in
differentiating between primary lung lesion and metastatic breast cancer [32]. Moreover, the
use of FSA is not recommended for the nodules smaller than 5 mm, as the FSA preparation
renders it impossible to obtain a permanent histological diagnosis afterwards [33].
Head and neck cancers include the cancers of oral cavity, pharynx and larynx, and account
for about 3.2% of all cancer incidences [34]. Especially for the early stage cancers it is critical to
limit extend of the resection in order to provide the best quality of life after surgery. A repeat
surgery is often not desired, especially in case of immediate reconstruction operations or due
to anatomical limitations [35]. Consequently establishing a negative margin with the initial
surgery becomes an important concern [36]. As an example, studies for oral cancers
demonstrated reduced 5 year survival rates as low as 50% for a positive margin, whereas the
survival can be as high as 91% for a negative margin and 85% for a close margin [37, 38].
Although FSA is shown to have high correlation with the permanent histology results of the
same tissue (89% and 99% sensitivity and specificity, respectively), in the same study it failed to
detect positive final margin in as high as 40% of patients [39]. In another large scale study on
4976 specimens, it is shown to have a 15% sampling error rate for head and neck tumor
resections [40].
With a 56,460 estimated new cases in 2012, thyroid cancer accounts for 3.4% of all cancer
incidences and is the most common malignancy of the endocrine system [34]. Although the
incidence of this cancer is relatively low and the survival rates for the diagnosed patients are
high (5 year survival rates >95%), the main challenge for the management of this disease is to
differentiate malignant lesions from benign lesions, as ultrasonography detects thyroid nodules
with a very high prevalence of up to 42% of the general population [41-43]. Fine needle
aspiration (FNA) cytology is the standard method for pre-operative assessment of the
malignancy of the thyroid nodules. Although the accuracy of this technique is close to 95%
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when a diagnosis has been made, about 20% to 33% of the FNA results as indeterminate for the
malignancy of the nodule [44-46]. Frozen section analysis (FSA) is proposed to be used to
determine the malignancy of the nodules during the initial thyroidectomy procedure, however,
it suffers from low sensitivity (~30%), hence has not gained clinical acceptance [47, 48].
Therefore, an accurate intraoperative assessment technique will be immensely useful in guiding
the extent of the thyroidectomy and preventing unnecessary total thyroidectomy procedures.
Apart from the applications mentioned in the following paragraphs that will benefit from
an imaging modality which provides real time intraoperative feedback, several other clinical
scenarios require real time, in situ assessment of the tissues in order to guide targeted biopsies,
to detect or diagnose malignant lesions, and to assess treatment response and efficacy.
Especially for a range of diseases related to human gastrointestinal (GI) tract, current strategies
for the detection and diagnosis of malignant lesions suffer from low yield, non specifity and
prolonged procedure times. Chapter 2 presents an in depth discussion on some of the pressing
challenges in the management of some of the highly prevalent GI diseases.
Optical coherence tomography (OCT) enables real-time, in vivo, micron-scale and three-
dimensional (3D) imaging of biological tissues without the need to sacrifice and process
specimens. OCT has been used for a wide range of clinical applications in human, including
ophthalmology [49-52], endoscopy [53-59], and cardiovascular imaging [60-64]. Optical
coherence microscopy (OCM) combines OCT with confocal microscopy and enables depth
resolved visualization of biological specimens with cellular resolution [65, 66]. OCM offers a
suitable alternative to confocal imaging by providing enhanced contrast due to the additional
coherence gate to the inherent confocal gate, increasing the field of view and imaging depth,
and eliminating the need of external contrast agents. Due to its unique advantages over
alternative real-time imaging modalities, a benchtop OCM system residing in the pathology
suite will be extremely beneficial for the clinical management of the cancer types described
previously. Furthermore, with the novel scanning mechanisms that have been developed in the
recent years it is possible to translate this imaging modality to an in vivo setting where a probe
can be inserted through the working channel of an endoscope or bronchoscope, and generate
cellular resolution images in real time without the need of external contrast agents.
This thesis describes the construction, characterization and preliminary imaging results of
a swept source OCM (SS-OCM) system utilizing a novel light source, Vertical Cavity Surface-
Emission Laser (VCSEL). This swept source laser can reach sweep rates exceeding 1 MHz and
provide wide tuning range, which will enable both imaging speeds approaching to time domain
OCM (TD-OCM) systems, and axial resolution approaching to spectral/Fourier domain OCM (SD-
OCM) systems. Two prototype VCSEL light sources, operating at 1060 nm and 1310 nm, have
been employed in this study that are developed with the collaboration of Thorlabs, Inc.
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(Newton, NJ) and Pravium Research, Inc. (Santa Barbara, CA). The 1060 nm and 1310 nm VCSEL
systems use the same sample arm optics whereas the fibers and couplers used in the
interferometer setup are tailored for the respective wavelengths. 1060 nm VCSEL is a prototype
turnkey operated light source which exploits optical clocking to acquire spectrums linear in
wavenumber. For the 1310 nm VCSEL, acquisition is performed also with optical clocking, as
well as by internally clocking the acquisition card and subsequent calibration of the spectrums
using Mach Zehnder interferometer (MZI) traces.
This thesis is developed in the following order:
Chapter 2 starts by describing endoscopic management and clinical challenges for a
spectrum of lower GI diseases where an in vivo OCM imaging probe can play a significant role in
the diagnosis and evaluation of the extend of the particular disease. Then, a review of
alternative imaging modalities, such as chromoendoscopy, narrow band imaging (NBI) and
confocal laser endomicroscopy (CLE) is presented, which outlines the relative strengths and
limitations of these imaging modalities in the context of management of lower GI diseases.
Chapter 3 gives an overview for the history of development of the OCM technology, with
a particular emphasis on their clinical applications. Discussion and comparison about the TD-
OCM, SD-OCM and SS-OCM imaging modalities is also included outlining the advantages and
disadvantages of each imaging method.
Chapter 4 begins with schematics of the overall system design, and then describes the
methods employed for the acquisition and calibration of the spectrums. In this context, a
detailed discussion on how the spectrums are calibrated for the internally clocked system, as
well as how optical clocking is achieved is also included. The discussion is followed by describing
some practical concepts in the system development and signal processing, such as
compensation for the scan curvatures, generating larger field of view mosaic images and
selection of suitable color maps for display. Finally, the performance of the system is assessed
by presenting measurements for the characterization of the imaging setup.
Chapter 5 presents example images obtained from ex vivo rabbit and human specimens,
using the 1060 nm and 1310 nm OCM systems. Rabbit samples include colon and kidney,
whereas samples from human include normal colon and invasive breast cancer specimens.
Demonstration of large field of view mosaic images is also included.
Chapter 6 summarizes the concepts and discussion presented throughout the thesis and
gives directions for the future development of the system.
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2. Lower GI pathologies and Endoscopic Imaging Methods
2.1. Background on Lower GI Diseases
Based on our groups longstanding collaboration with Drs. Hiroshi Mashimo, MD, PhD and Qin
Huang, MD, PhD, at Department of Gastroenterology at the VA Boston Healthcare System, as
well as Dr. James Connolly, MD, at Department of Pathology at the Beth Israel Deaconess
Medical Center (BIDMC), and the scope of some of the major National Institute of Health (NIH)
grants that financially supports us, our group puts a strong emphasis on OCT and OCM
applications for diseases related to human GI tract. In the past, the focus of the research of our
group was to identify and survey a set of premalignant conditions mainly related to upper GI
tract. Earlier studies have confirmed the utility of OCT by showing correlation between OCT
images and histological appearance of related upper GI architectures, such as squamous
epithelium, Barrett's esophagus (BE), low and high grade dysplasia (LGD, HGD), and
adenocarcinoma [1-5]. In a study with 55 patients, a blinded read of OCT and corresponding
histology images has shown a sensitivity of 83% and specifity of 75% for detecting HGD and
intramucosal carcinoma [6]. Although in this study HGD and advanced carcinoma was grouped
together, the main clinical challenge is to distinguish Barrett's epithelium with dysplasia from
BE without dysplasia, as adenocarcinoma and intramucosal carcinoma is readily identifiable by
endoscopy. In a prospective, double blinded study with 33 patients, the utility of OCT for
detecting dysplastic BE is found to be relatively low with a sensitivity of 68% and specifity of
82% [7]. Another study investigated methods for computer aided classification techniques for
identifying dysplasia and found a sensitivity of 82% and specifity of 74% for a relatively low
patient population of 13 patients [8].
Note that earlier endoscopic OCT studies have utilized imaging catheters wit relatively low
resolution (~10 - 15 um), which might have impacted the low diagnostic accuracy observed in
those studies. Subsequently, with the advent of broadband, high speed swept source lasers and
improved imaging catheters, high resolution (9 um transverse and 7 um axial) imaging has been
demonstrated in vivo [9]. Furthermore, pilot studies utilizing Doppler OCT methods have shown
characteristic flow patterns related to normal esophagus, Barrett's esophagus and
adenocarcinoma [10]. Moreover, using a balloon based imaging catheter, comprehensive
surveillance of long segments of esophagus (> 5 cm) has been performed [11, 12]. More
recently, using the unique advantage of OCT imaging which provides depth resolved images,
our group have demonstrated the high prevalence of "buried" BE glands for the patients
undergoing radiofrequency ablation (RFA), which are invisible during standard white light
endoscopy (WLE) and has been argued to have malignant potential [13]. In another study, we
found a correlation between the quantity of these buried glands and the efficacy of the RFA
treatment [14]. Furthermore, the same study also showed a correlation between the thickness
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of the Barrett's epithelium and the success of the subsequent treatment response. With the
substantial increase in the axial and transverse resolutions, as well as the imaging speed of the
new generation OCT systems, it can be expected that more studies will be conducted on upper
GI diseases to further tackle the long standing clinical challenges such as detecting dysplasia in
BE patients and improving the efficacy of treatment strategies.
Recently, the interest of our group in lower GI pathologies has been grown due to long
standing and emerging clinical challenges related to some of the highly prevalent colorectal
diseases. It is our belief that OCT and OCM imaging have several distinguishing features, such as
high resolution, depth resolved imaging capability, deep tissue penetration and non-reliance on
external contrast agents, which can make these imaging modalities promising technologies in
tackling some of the issues faced in the management of a major subset of lower GI diseases. In
the following sections, three of these diseases will be analyzed by highlighting the clinical
challenge and indicating limitations of WLE for these particular applications. Note that, in the
following the terms endoscopy and colonoscopy will be used interchangeably where both refer
to conventional endoscopic procedure performed with WLE.
i. Detection of Non-polypoid (flat) Lesions
With 103,170 estimated new cases in 2012, colorectal carcinoma (CRC) is the third most
common cancer, as well as the third most common cause of cancer related deaths for both
sexes in the U.S. [15, 16]. Approximately two-thirds of all CRC cases progresses through a
relatively well defined pathway, which involves the transformation from normal epithelium to
low-grade dysplastic adenoma, and then to protruding adenoma with high grade dysplasia or
villous component, which finally progresses to invasive cancer, accompanied by a series of
genetic mutations, including mutations in APC, KRAS and p-53 genes [17, 18]. For the case of a
well defined protruding lesion, a polypectomy procedure is performed to remove the
adenomatous lesions. The latest update on the National Polyp Study, an ongoing randomized
trial (starting from 1990) to evaluate effective surveillance of patients discovered to have
colorectal adenomas, demonstrated a reduction of 53% in CRC related mortality with
colonoscopic polypectomy (population wide mortality was 0.46% vs. 0.97% for with and
without polypectomy, respectively) [19]. Similar to the result of this study, several other studies
in U.S. and other nations proved the effectiveness of colonoscopy as a screening tool, with a
reduced CRC incidence rate of 29-77% [20-23].
Non-polypoid colorectal neoplasms (NP-CRNs) depicted in Fig. 1, on other hand, show
only slight morphological difference from the surrounding epithelium, making it harder to
detect using conventional endoscopic imaging modalities [24, 25]. Although several definition
exist on what constitutes this category of polyps, a polyp whose height is no more than its
diameter or, more quantitatively, polyps with less than 3 mm vertical elevation are usually
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considered as flat lesions [26, 27]. Tied to the challenges for the detection of the non-polypoid
lesions, the population wide prevalence of these category of polyps is not well known, yet a
range of numbers between 7% to 45% exist for the prevalence of these lesions, with a clear
increasing trend as more advanced imaging methods are employed aiding the detection of
these lesions [28-32]. Moreover, these lesions is shown to exist throughout the lower GI tract,
58% of which residing in the left colon and 42% residing in the right or transverse colon [32].
0-Ip 0-Is
Protruded, pedunculated Protruded, sessile
0-I-c0-H1a 01
Superficial, elevated Flat Superficial shallow,
depressed
0-Ill
Excavated
Figure 1: Schematic representation of major variants of colonic lesions. 0-Ip and 0-Is
represents polypoid lesions, readily identifiable by WLE. 0-11a, 0-llb and 0-Ilc, on the other
hand, are non-polypoid lesions and they are harder to detect using standard endoscopic
imaging modalities. Figure is modified from [33].
In a cross sectional study with 1,819 patients undergoing elective colonoscopy, the
malignant potential of NP-CRNs have been found to be much higher than polypoid lesions, with
an odds ratio of 9.78 (95% Cl, 3.93 - 24.4) for the likelihood of containing carcinoma [34]. In the
same study, non-polypoid lesions accounted for 54% of superficial carcinomas. Moreover,
about 8.6% of the non-polypoid lesions was categorized as depressed lesion, with a risk of
malignancy as high as 33% [34]. Several other studies confirmed the higher malignancy of the
depressed lesions, by showing that 75% of all early CRCs have a depressed component, and
29.5% of all depressed lesions are malignant irrespective of size, with the overall risk of
carcinoma increasing above 80% when the size of the lesion is larger than 15 mm [35, 36].
Despite its extremely high potential of malignancy and its high prevalence among
population, the miss rates of the non-polypoid lesions during WLE are very high, even when the
endoscopy procedure is conducted by expert endoscopists. In a retrospective study with 76
colonoscopy pairs it has been found that 17% of patients had one or more neoplastic polyps
missed in the initial imaging session [37]. Other retrospective studies confirmed the high miss
rate of WLE, especially for the flat appearing lesions [38, 39]. Furthermore, several prospective
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studies that featured back to back colonoscopy by two different endoscopists demonstrated
that about 16-27% of small polyps (<5 mm) falling into this category are missed by WLE [40, 41].
Hence it is clear that there is a need for an imaging modality that will increase the yield of
surveillance endoscopy for the detection of the non-polypoid lesions.
ii. Differentiation Between Forms of IBD
Chron's disease (CD) and Ulcerative colitis (UC) constitutes two major forms of chronic
inflammatory bowel disease (IBD), with an estimated number of 1.5 million total cases in the
U.S. [42, 43]. The chronic nature of this disease manifest itself as a significant economical
burden, producing a total of $6.3 billion annual cost for IBD-associated treatment in U.S. [44].
For an established IBD case, the differential diagnosis between CD and UC is crucial, as the
clinical management and prognosis for these two forms of IBD are vastly different. For instance,
antibiotics are shown to be more effective in CD patients compared to UC patients [45].
Moreover, for UC patients, surgical intervention to remove the inflammatory lesion followed by
an ileal puch-anal anstomosis (IPAA) procedure is considered as an effective treatment,
whereas CD is generally considered incurable, and the management strategies focus on
maintaining symptomatic control, improving quality of life and minimizing short and long term
toxicity as well as complications [46, 47]. As an example, the IPAA procedure performed on CD
patients result in pouch complications in as high as 40% of patients [48].
There are several morphological and structural features that aid in the differentiation
between these two forms of IBD. In general, UC involves the rectum and might affect part or
the entire colon in a continuous pattern, with inflammation mainly limited to the mucosa layer.
On the other hand, any site of the lower GI tract can be affected with CD, but it is most
common to the ileum and colon with a skip or patchy involvement [49]. Different form UC, CD is
characterized with a transmural inflammation and often associated with intestinal granulomas,
strictures, and fistrulas [42, 43].
Despite many clinical, anatomic and histologic distinctions, there is still no gold standard
of diagnosis between these two forms of IBD [50]. Consequently, several prospective and
retrospective studies have shown that in 5-15% of cases a definite distinction between UC and
CD can not be made, and the disease is classified as indeterminate colitis (IC) [51, 52]. Even
when an endoscopic resection is performed, the pathological diagnosis is correct only in 87% of
cases [53]. Several serologic, proteomic and genetic analyses were also tested for the
differentiation between the two forms of IBD, however, their sensitivity remain too low for
them to be adapted into the standard of care [54-56]. Therefore, it is clear that an imaging
modality that will enable accurate differential diagnosis between UC and CD will make a
significant impact on the clinical management of IBD.
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iii. Detecting Dysplasia in IBD Patients
The prognosis for CRC patients with a history of longstanding IBD is shown to be worse by
population based studies, with a mortality rate ratio of 1.24 for UC patients and with a hazard
ratio of 1.82 for CD patients, compared to CRC patients without IBD [57, 58]. Furthermore,
several studies established the increased risk of developing CRC for IBD patients. A large meta-
analysis based on 194 studies showed the risk of cancer for UC patients as 2% after 10 years,
and as high as 18% after 30 years of long standing disease [59]. A similar risk factor has been
reported in another prospective follow up study with 600 patients (2.5% at 20 and 10.8% at 40
years) [60]. Similar population based studies and meta-analyses conducted with CD patients
confirmed an increased risk of developing CRC equal to UC patients [61, 62]. There are also
some recent studies, however, which suggest a decrease in the absolute risk of developing CRC
in IBD patients, which might be attributed to more comprehensive surveillance programs or the
effect of anti-inflammatory medications [63-65]. Several risk factors such as duration of the
disease, degree of inflammation, concurrent diagnosis of primary sclerosing cholangitis (PSC),
family history, gender, and age of onset of the IBD has been associated with an increased risk of
developing CRC for IBD patients [60, 66-69].
Due to high risk of developing CRC, current American Gastroenterology Association (AGA)
guidelines recommends screening colonoscopy for IBD patients with 1-3 year intervals, at a
maximum of 8 years after onset of the disease, which consists of obtaining 4 quadrant random
biopsy specimens every 10 cm throughout the entire colon [70]. However, this approach is
prone to sampling errors as several studies showed that in 50-80% of cases with colitis-
associated neoplasms, the lesions are not visible upon WLE [71]. One study with 590 patients
who underwent proctocolectomy showed that preoperative colonoscopy led to the correct
identification of the lesion only in 39.7% of cases, and the positive predictive value of finding
preoperative dysplasia of any grade was 50% [72]. A meta analysis conducted on 10 prospective
studies with a total of 1,225 patients showed that 37% of patients with indefinite results for
malignancy during colonoscopy progressed to high grade dysplasia or cancer [71]. Therefore,
to date, no randomized prospective studies have shown that surveillance colonoscopy indeed
reduces the risk of CRC development in IBD patients [73].
The purpose of surveillance in IBD patients is to detect dysplastic progression of the
mucosa, as this is thought to be the best marker for CRC risk in IBD patients [74]. Lesions
suspicious for dysplasia are categorized into dysplasia associated lesion or mass (DALM) or
adenoma like mass (ALM). The differential diagnosis of the suspected lesion between these two
categories is critical for the clinical management of the disease. For ALM, polypectomy is
considered to be a successful tool for the removal of malignancy based on the results of several
studies [75-77]. Even in the case of high grade dysplasia, endoscopic resection is shown to have
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no significant excess risk for the development of CRC for the IBD patients with ALM [78]. On the
other hand, DALM is shown to correlate with synchronous or metachronous carcinoma, and
involvement of invasive carcinoma is shown in up to half of cases. Hence, colectomy is the
standard of care for the IBD patients with a diagnosed DALM [70]. Note that in both cases
removal of the entire dysplastic lesion is essential. Especially for the case of endoscopic
resection, residual flat dysplastic lesion around the boundaries of the primary lesion is shown to
develop into CRC in almost 40% of cases [79].
Despite the importance of differentiating between DALM and ALM, pathological
differences between these two lesions are rather subtle such that making a correct diagnosis
during the endoscopy procedure is a major concern [80]. Unfortunately, WLE performs poorly
for this purpose, as prospective studies have shown an accuracy of 68% and 75% for the correct
diagnosis of ALM and DALM, respectively, even when the diagnosis is made by an expert
pathologist [81, 82]. For academic gastroenterologists, who are argued to have less endoscopic
work load and experience, the accuracy decreases to as low as 58% and 56% for the correct
diagnosis between ALD and DALM, respectively [81]. Hence there is a marked need for an
imaging technology that will aid in differentiation of DALM from ALM, and increase the yield in
detecting dysplasia in IBD patients.
2.2. Advanced Imaging Techniques for Management of Lower GI Diseases
In the previous section a set of diseases related to lower GI tract has been described, where the
utility of conventional WLE is limited in the diagnosis and management of the related condition.
In the past decades, several imaging modalities have been developed and applied to the realm
of endoscopic imaging, in an attempt to increase the yield of the lower GI surveillance
strategies. In this section, a review of some of the most promising endoscopic imaging
modalities will be given with a special emphasis of their advantages, limitations, results of
controlled comparison studies, and the adaptation of the related technologies into the GI
community.
Identification of Fine Surface Structures (Pit Patterns) of the Colonic Mucosa
One of the characteristics of the colon is the presence of well defined crypt like structures
(pit patterns) that lines the superficial layer of the colonic mucosa [83]. Although too small to
be discernible with conventional WLE, the advent of the advanced imaging modalities such as
magnification endoscopy, narrow band imaging (NBI) and chromoendoscopy made it possible
to observe these structures during the endoscopic session. Hence, several classification
schemes have been developed in conjunction with the exploration of the various types of crypt
patterns and the underlying pathological condition [84]. Among these, the classification scheme
developed by Kudo et al. has gained widespread acceptance within the GI community, hence
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"Kudo's pit pattern" became the common nomenclature for describing the category of the
colonic crypt structures [85, 86].
Figure 2 depicts the Kudo classification of colonic pit patterns that is widely used in the GI
community. In this figure, Type - I refers to roundish crypt structure where each crypt has about
0.07 ± 0.02 mm diameter [84]. This type of pit pattern is the characteristic of normal colonic
mucosa. Type - II, on the other hand, consists of larger pits with a diameter of 0.09 ± 0.02 mm,
where the crypts have stellar of papillary appearance. This type of pit pattern is associated with
the presence of a hyperplastic polyp with an accuracy of as high as 95.5% [87]. The elongated
roundish pits in Type - IIIL have a diameter of 0.22 ± 0.09. On the other hand, Type - IllS
consists of smaller (diameter of 0.03 ± 0.01 mm) elongated roundish pits. Adenomas with a
Type - IIIL pit pattern account for the majority of colorectal neoplasms, whereas Type - IllS is
usually associated with the presence of a depressed lesion [88]. Type - IV features the largest
crypts with a diameter of 0.93 ± 0.32 mm that are typically in branched form. Finally, Type - V
pit pattern consists of disarrayed crypt structures that do not show any structural
characteristics. The malignancy potential of Type - IV and Type - V pit pattern is shown to be
very high, where Type - IV typically belongs to a protruded tumor and Type - V is often
associated with submucosal or advanced carcinoma [88-91].
Type I round pits
Type 1i stellar or papillary pits
Type M L large tubular or roundish pits
Type I s small tubular or roundish pits
Type IV branch-like or gyrus-like pits
Type V non-structural pits
Figure 2: Classification of colonic pit patterns developed by Kudo et al. Figure is modified from
[89].
Due to this intimate relationship between the morphology of the colonic pit patterns and
the histopathological state of the tissue, the main objective of some the imaging modalities
that will be discussed next will be to provide necessary contrast and magnification to enhance
the visualization of the pit patterns during the endoscopy procedure.
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i. Narrow Band Imaging (NBI)
In narrowband imaging, the tissue is illuminated by two discrete signal bands, one centered at
450 nm (440-460 nm), and the other band centered at 550 nm (540 - 560 nm) [92]. It is well
known that hemoglobin has high absorption at these spectral bands. Hence, light will be
attenuated from the vessels and capillaries, which will result in enhanced identification of the
mucosal surface patterns. Figure 3 demonstrates the utility of NB in terms of enhancing the
contrast of the colonic architecture. Especially the magnified views shown in Fig. 3 (C) and (F)
shows clear delineation of irregular pit patterns and the vascular network. Note that, in terms
of instrumentation, only two narrowband optical filters are required, hence this method can be
readily integrated into existing endoscopes. Hence, newer models of the endoscopes and
colonoscopes from major endoscope manufactures indeed feature this imaging modality.
Figure 3: Enhanced visualization of colonic architecture and vessels due to NBL. (A) to (C) show
a 3 mm sessile hyperplastic polyp whereas (D) to (F) show a 4 mm sessile adenoma. (A,D) are
taken with WLE, (B,E) are taken with NB1 and (C,F) are taken with NBI with magnification.
Figure is modified from [93].
Due to its increased contrast for the surface morphology, initially there was a high
optimism for the utility of NBI for the detection of polypoid and non-polypoid adenomas [94].
However, subsequent large scale randomized control studies have shown no significant
increase in the adenoma detection rates with NBI. A study conducted by a single endoscopist
on 434 patients resulted in an adenoma detection rate of 65% with NBI as compared to 67%
with WLE [95]. Moreover, no significant improvement in the flat lesion detection rate is noted
in the same study. In another prospective randomized control study, conducted by 7
endoscopists with no prior NBI experience, the detection rate of adenomas for NBI and WLE
was as low as 23% and 17%, respectively [96]. Another recent multicenter study involving 1,256
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patients, conducted by 6 experienced endoscopists with some prior NBI experience, has shown
the detection rate as 33% with NBI and 37% with WLE [97]. Note that in these studies adenoma
detection rates are defined as the number of patients that have been detected to have
adenomas divided by the total number of the patients in the study.
There are also some tandem studies that showed a slight increase in the adenoma
detection rates with NBI. In one study with 62 patients, single experienced endoscopists
performed WLE followed by NBI. The results showed that the adenoma detection rates are 27%
for NBI whereas it is 15% for WLE [98]. In a larger scale study 276 patients have been
randomized to either WLE or NBI examination [99]. Afterwards, all patients have been
underwent a second procedure with WLE as the reference standard. The adenoma detection
rates are shown only marginally higher for NBI (50% with NBI vs. 44% for WLE). Note that
despite the results showing some improvement for the adenoma detection rate with NBI for
the tandem studies, these studies have been criticized as blinding of the endoscopists is not
possible due to the nature of the study [94]. Overall, a pooled analysis on different studies
concluded that NBI is only marginally better than WLE for adenoma detection [100].
Although it seems that NBI might have less utility in the detection of lesions, it might have
a better potential in characterization and differentiation of colonic lesions. In one prospective
comparative study with 133 patients, the diagnostic accuracy of NBI is shown to be significantly
higher than WLE (p = 0.04 and p = 0.004 for two different readers) and it was comparable to
that of chromoendoscopy [101]. In this study sensitivity and specifity of NBI was 87%/88% and
95%/71%, respectively, for reader 1/reader 2, as opposed to being 62%/65% and 85%/74%,
respectively, for WLE. Yet in another prospective comparative study with 78 patients, the
sensitivity and specifity of NBI for differential diagnosis of neoplastic (adenoma,
adenocarcinoma) and non-neoplastic (hyperplastic) polyps was 95.7% and 87.5%, respectively,
with an overall diagnostic accuracy of 92.7% [102]. The sensitivity and specificity of WLE for the
same diagnosis was significantly lower in the same study (82.9% sensitivity, 80% specifity).
Several other smaller scale studies have further confirmed the utility of NBI for the differential
diagnosis of the colorectal lesions [98, 103, 104]. Note that, in some of these studies the
appearance of the vessel structures has been taken into consideration in addition to pit
patterns. Due to the high hemoglobin absorption at the illumination wavelengths, as previously
mentioned, NBI also enhances the visualization of the vessel and capillaries by this negative
contrast mechanism. Hence, it should be emphasized that this advantage of NBI can provide
additional diagnostic information.
The utility of NBI for detection of dysplasia in IBD patients is not studied in detail. One of
the few studies on this subject has shown that NBI detects neoplastic lesions at a rate
comparable to WLE (24% and 23% for NBI and WLE, respectively) [105]. However, this study
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utilized an early generation NBI system. It is argued that the newer generation NBI systems,
combined with magnification endoscopy, can enhance the detection of dysplasia for IBD
patients [106].
ii. Chromoendoscopy
Chromoendoscopy involves the topical application of specific dyes to enhance the visualization,
characterization and diagnosis of mucosal surface structures [107]. As it is the case with NBI, it
does not require any sophisticated equipment and can be readily performed using standard
endoscopes. The application of the dye requires a spraying catheter, introduced through the
working channel of the endoscope. For diagnosis purposes the dyes can be sprayed solely onto
the suspected lesions, whereas for detection of lesions they can be sprayed homogeneously
throughout the colon, a procedure termed as pancolonic chromoendoscopy [108].
There are three commonly used Chromoendoscopy dyes in the GI tract that can be
broadly categorized into either absorptive (vital) or contrast stains [109]. Absorptive dyes
include Lugol's iodine and methylene blue. Lugol's iodine has an affinity for glycogen in
nonkeratinized squamous epithelium. Normal squamous epithelium stains with black or brown
colors, whereas an abnormal stain pattern indicates a condition related to the disruption of the
epithelial structure. Hence it is commonly used for diseases related to upper GI tract, namely
esophagus, whose characteristic lining consists of squamous epithelium. Consequently, several
studies have established its efficacy on the detection of esophageal malignancies, with a
sensitivity reaching to 96% for the detection of high grade dysplasia or cancer for squamous cell
carcinoma of the esophagus [110, 111]. On the other hand, methylene blue is taken up by
actively absorbing tissues such as small intestinal and colonic epithelium and does not stain non
absorptive epithelia such as esophageal mucosa. Hence, the presence of this stain in the
esophagus highlights malignancy, whereas lack of stain in the colon can be related to the
presence of a metaplastic, neoplastic or inflammatory change [112-114]. Methylene blue has
been used in a variety of GI applications, which includes improving the diagnosis of early gastric
cancer, highlighting mucosal changes in celiac disease, detection of intestinal metaplasia in
Barrett's esophagus, detection of colonic neoplasia, and differentiating between neoplastic and
non-neoplastic lesions in IBD patients [114-118]. Figure 4 demonstrates the utility of
chromoendoscopy in detecting the regions in the esophagus that have abnormal epithelial
lining.
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Figure 4: Enhanced visualization of mucosal architecture with chromoendoscopy. (A) is a WLE
image of a BE patient with high grade dysplasia whereas (B) is the chromoendoscopy image of
the same region after the methylene blue stain whereas (C) shows a region with squamous
cell carcinoma of the esophagus after Lugol's iodine. Figure is modified from [119].
Indigocarmine, as opposed to the absorbing stains mentioned previously, pools into the
mucosal cervices and pits, highlighting the fine features of the surface topography [109]. As
shown in Fig. 5, pit patterns are clearly delineated with chromoendoscopy using the
indigocarmine stain. Because of its superiority in defining irregularities in the mucosal
architecture, it has been widely used for the detection and diagnosis of colorectal lesions. Note
that, unless otherwise noted, all the chromoendoscopy studies described next were conducted
with Indigocarmine as the staining agent.
F
Figure 5: Visualization of pit patterns with Chromoendoscopy stained with indigocarmine. (A)
to (E) show Type - I, Type - II, Type - Ills, Type - IllL and Type - V Kudo pit pattern, respectively.
Figure is modified from [89].
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As was the case with NBI, studies have shown a high diagnostic accuracy of
chromoendoscopy for the differentiation between colonic lesions. In one large scale
retrospective study consisting of images from 923 polyps, the sensitivity and specifity of
chromoendoscopy for the differential diagnosis between neoplastic and non-neoplastic lesions
is found to be 92% and 73.3%, respectively, with an overall diagnostic accuracy of 88.4% [120].
In another retrospective landmark study involving 3,438 lesions from 4,445 patients have
shown that the diagnostic accuracy of chromoendoscopy is 75% for non-neoplastic lesions, 94%
for adenomatous polyps, and 85% for invasive carcinoma [121]. In another large scale
prospective study with 954 polyps, the sensitivity and specifity of chromoendoscopy for
comparing histologically confirmed neoplastic lesions to non-neoplastic lesions was found to
be 90.8% and 72.7%, respectively [122]. Several other studies have confirmed the diagnostic
accuracy of chromoendoscopy for the classification of colorectal lesions [123-126]. A pooled
meta analysis including 27 of the large scale studies on this subject has indicated the sensitivity
and specifity of chromoendoscopy for differentiating between malignant and non-malignant
lesions as 94% (95% Cl, 92% - 95%) and 82% (95% Cl, 72% - 88%), respectively [127].
The utility of chromoendoscopy for the detection of non-polypoid lesions is more
promising than NBI discussed in the previous section. In one of the largest randomized multi
center control trials on this subject, which included 1,008 patients randomized to
chromoendoscopy (N = 496) and WLE control (N = 512) groups, it has been shown that
pancolonic chromoendoscopy has increased the overall detection rate for protruded adenomas
(0.95 vs. 0.66 per patient), flat adenomas (0.56 vs. 0.28 per patient) as well as serrated lesions
(1.19 vs. 0.49 per patient, p<0.001) [128]. Another randomized control study involving 660
patients have also found increased detection rates for flat adenoma (0.6 vs. 0.4 per patient, p =
0.01), for adenoma smaller than 5 mm (0.8 vs. 0.7 per patient, p = 0.03), and for non-neoplastic
lesions (1.8 vs. 1 per patient , p<0.0001) with chromoendoscopy compared to WLE [129]. Note
that, the yield of detection of advanced neoplasia with chromoendoscopy was found similar to
WLE in the same study. Several other prospective control studies have been confirmed the
efficacy of chromoendoscopy in detecting lesions not discernible under conventional WLE [130-
132].
Chromoendoscopy is also shown to be a promising modality for the detection and
classification of dysplasia in IBD patients. In a single arm study involving 117 surveillance
colonoscopies, chromoendoscopy is shown to have a sensitivity of 85.7% and specifity of 88.5%
for the differential diagnosis between low grade dysplasia (LGD) and high grade dysplasia
(HGD)/carcinoma (CA) for IBD lesions [133]. In another, prospective tandem study which
involved back to back colonoscopies, where standard WLE is followed by chromoendoscopy,
114 additional abnormalities from 55 patients have been identified by chromoendoscopy, all of
which were considered to be adenomas [134]. This study further revealed a statistically
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increased dysplasia detection rate and increased yield for targeted biopsies due to the
application of chromoendoscopy. In one of the landmark studies on this subject, which
consisted of a randomized controlled trial involving 262 IBD patients, significantly more
intraepithelial neoplasia were detected in the chromoendoscopy group compared to the
conventional WLE group (32 vs. 10, p = 0.003) [114]. Furthermore, using the Kudo pit pattern
classification, the sensitivity and specifity for differentiation between neoplastic and non-
neoplastic lesions is reported as 93% in the same study. Several other studies further validated
the utility of chromoendoscopy for the endoscopic management of IBD patients [135, 136].
The advantages of chromoendoscopy discussed in this section are offset by an increase in
procedure time, higher cost and a labor intensive procedure. Apart from the time required for
spraying of the stain, especially for the case of pancolonic chromoendoscopy, an extremely high
quality bowel preparation is also required for the procedure to be successful. In a study
described earlier, as high as 158 patients among the total study population of 1,008 patients
had been excluded from the study solely based on inadequate bowel preparation [128]. It has
been also argued that the gain in the adenoma detection rates can be due to improvements in
the standard endoscopy technology, such as the introduction of high definition endoscopy and
magnification endoscopy [137]. Furthermore, the false negative rate of this technique, being as
5.7% in the pooled meta-analysis for the assessment of colorectal neoplasms, has been
criticized as unacceptably high [127]. All in all, due to these apparent limitations,
chromoendoscopy has not been integrated yet into the routine clinical practice [94].
iii. Confocal Laser Endomicroscopy
Confocal microscopy utilizes a small pinhole aperture imaged onto the sample, which enables
the rejection of the light scattered from out of the focus of the objective [138-140]. Compared
to conventional microscopy, the use of point illumination on the sample and spatial filtering on
the detector has the advantages of providing sharper images by increasing the effective axial
resolution of the system (termed as confocal gate), as well as improving the contrast by
increasing the signal to noise ratio (SNR) by rejecting scattered light from out of focal plane
[141]. For the last several decades this imaging technology has been found applications in many
areas of biological sciences and biomedicine, in form of a benchtop microscopic imaging system
as well as an in vivo cellular resolution imaging platform [142-146].
Confocal laser endomicroscopy (CLE) is the integration of confocal imaging into the
endoscopic setting. Currently there are two FDA approved CLE imaging platforms available to
use in the U.S. The first system, iCLE (Pentax Endomicroscopy, Japan) is an integrated system
that features both standard endoscopic imaging as well as the confocal imaging [147]. The
second system is a probe based confocal imaging system, pCLE (Cellvizio Endomicroscopy, MKT,
28
France), where the imaging catheter is advanced through the working channel of a standard
endoscope [148]. Several key features of these two systems are compared in Table 1.
iCLE pCLE
_________ Low Res High Res
Imaging Depth (um) 0-250 70-130 55-65
Field of View (um) 475 x 475 600 240
Lateral Res. (um) 0.7 3.5 1
Axial Res. (um) 7 15 5
Frame Rate (fps) 0.8 12 12
Number of pixels 1 megapixel 30,000 pixels 30,000 pixels
Table 1: Comparison of two commercially available confocal imaging systems.
As can be seen from Table 1, pCLE system has two probe options. The lower resolution
probe provides larger field of view at a cost of lower resolution. The higher resolution probe, on
the other hand, compares with the iCLE system in terms of resolution. One major difference
between the pCLE and high resolution iCLE is that the focus of the former system can be
adjusted from 0 um to 250 um, whereas the probe of the pCLE has a fixed focus around 60 um
below the tissue contact. Moreover, the field of view of the iCLE is twice larger than pCLE, as
well as it has significantly higher pixel density. On the other hand, pCLE has an increased frame
rate compared to iCLE. Arguably the most significant advantage of pCLE is its compatibility with
any endoscope with a working channel of at least 2.8 mm. In order to use iCLE, however, a
complete endoscopic imaging platform needs to be purchased, which is a limiting factor for
established endoscopy suites. Furthermore, the current iCLE product features a standard
resolution WLE, whereas pCLE can be used with high resolution endoscopes as well. Due to
these reasons, a majority of CLE studies especially in the U.S. employs a pCLE system for
imaging.
For both of the CLE systems, extrinsic contrast is achieved by the intravenous
administration of fluorescein. The leakage of fluorescein from the vessels provides the contrast
in the images, where the capillaries and extracellular matrix appears bright and the cells and
nuclei appears as dark structures. The topical agent Acriflavine has also been used, which
provides nuclear contrast by staining the nuclei, however, it is not approved to in vivo use in the
U.S. due to its mutagenic potential [149, 150]. Therefore, unless noted otherwise all the studies
discussed next are used fluorescein as the contrast agent.
Miami classifications outline a consensus among endoscopists and confocal imaging
experts for a classification system to distinguish normal and pathological states for a variety of
GI diseases, including Barrett's Esophagus, biliary disease, colorectal disease, as well as gastric
and duodenal diseases [151]. For colonic diseases, this classification scheme uses a combination
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of structural changes in the crypt architecture, such as the formation of irregular and villiform
structures, as well as changes in the size and organization of the vessels and capillaries to
diagnose and classify neoplastic progression. As an example, normal colonic structure is defined
as having round crypt structures, dark goblet cells and narrow vessels surrounding crypts in the
CLE images, whereas disorganized/loss of villiform structures, presence of dark, irregularly
thickened epithelium and dilated vessels are hallmark characteristics of adenocarcinoma.
As opposed to NBI and chromoendoscopy, the limited field of view of CLE renders this
imaging modality impractical for the detection of colonic lesions during surveillance. However,
it can still provide benefit to improve diagnostic accuracy and provide the acquisition of
targeted biopsies when it is used in conjunction with a "red flag" imaging modality such as
chromoendoscopy [152]. In a prospective, blinded study with 69 patients on 390 different
imaging locations, iCLE has predicted neoplastic changes (intraepithelial neoplasia and
colorectal cancer) in the lower GI tract with as high as 97.4% sensitivity and 99.4% specifity
[153]. Another study compared the diagnostic accuracy of chromoendoscopy and CLE to detect
malignancy in a total of 119 polyps from 75 patients [154]. Although there were no statistically
significant differences in the specifity of the two imaging modalities, the sensitivity of CLE was
91%, whereas the sensitivity of WLE was found to be 77%. Another study compared CLE and
chromoendoscopy for detecting residual neoplasia at the endoscopic mucosal resection (EMR)
scars, and similar to the aforementioned study, CLE yielded better sensitivity and specifity
compared to chromoendoscopy (97% sensitivity, 77% specificity vs. 72% sensitivity, 77%
specificity for CLE vs. chromoendoscopy, respectively) [155]. Similar studies comparing CLE and
NBI also showed improved diagnostic accuracy for CLE [156]. These studies demonstrate that
the high resolution imaging capability of confocal imaging provides a high diagnostic accuracy
once a suspected region can be identified with the aid of WLE, chromoendoscopy or NBI.
The use of chromoendoscopy and CLE in combination is proven to be effective in
increasing the yield of neoplasia in IBD patients as well. In one prospective study where 73
patients randomized to the conventional colonoscopy group and 80 patients randomized to the
CLE group, a 4.75 fold increase in the detection rate of intraepithelial neoplasia has been
observed [157]. In the same study, CLE predicted the presence of neoplastic changes with 95%
sensitivity and 98% specifity. In another study which investigated the utility of CLE in
differentiating between DALM and ALM showed an accuracy of as high as 97%, with the kappa
coefficient for the agreement between histology and CLE being 0.91 [158]. Several other
feasibility studies have been further demonstrated the utility of CLE in detecting the neoplastic
changes and differentiating between benign and malignant lesions in IBD patients [159, 160].
In summary, studies utilizing CLE have been shown the benefit of this imaging technology
which offers in vivo assessment of pathological state of tissues with cellular resolution.
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However, since the field of view of CLE is limited, as well as it often requires contact with the
tissue, it is found to be unfeasible to use this modality by itself for the detection of colorectal
malignancies. Hence an accompanying imaging modality such as NBI or chromoendoscopy is
necessary to be used in conjunction with CLE in order to increase the overall yield of detection
and reducing the sampling errors due to random biopsies. Another limitation of CLE is the lack
of nuclear contrast due to the use of fluorescein, which makes it challenging to detect and
classify early neoplastic changes, such as differentiating between low grade dysplasia and high
grade dysplasia. Moreover, the acquisition of single depth in pCLE, and limited total imaging
depth of iCLE makes this modality suitable to image only the superficial structures, which
occludes extraction of some critical diagnostic information such as detecting mucosal invasion
or staging neoplasia. Finally, it should be noted that even for prospective studies, readings of
confocal images were often done in a retrospective setting, by selecting exclusively high quality
images among the images generated throughout the imaging session. However, the diagnostic
accuracy of CLE for the studies that involved real time diagnosis of malignancy showed
significantly less sensitivity and specifity compared to aforementioned studies, which was
related to the poor quality of confocal images for the overall imaging session [161]. Therefore,
although CLE is a promising imaging modality for lower GI applications, there are several
challenges that need to be addressed in order for this technology to gain clinical acceptance.
iv. Optical Coherence Tomography
The utility of OCT for the in vivo detection and diagnosis of lower GI diseases has not been
investigated thoroughly so far, although several feasibility studies have been conducted. Earlier
studies have demonstrated the superiority of OCT compared to endoscopic ultrasound (EUS) in
terms of spatial resolution [162]. Another study demonstrated a strong correlation of OCT
images and histology, in terms of classifying the mucosal and submucosal layers of the lower GI
tract, although this study was conducted with ex vivo specimens [163]. In one study OCT has
been used to identify regions of active inflammation in UC patients based on alterations in the
layered architecture of the colon [164]. Involving 27 patients, this study achieved a sensitivity of
100%, whereas the specifity was as low as 69%. Similarly, in another, ex vivo study using OCT as
the imaging modality, a sensitivity of 86% and specifity of 91% has been achieved in
differentiation between UC and CD for IBD patients [165]. The same study has been also
conducted in vivo with the involvement of 40 CD and 30 UC patients, where a sensitivity and
specifity of 90% and 83%, respectively, has been demonstrated [166]. Note that in both of
these studies the main diagnostic feature for the OCT images was the presence or absence of
the appearance of the layered architecture for the cross sectional colon images, as any
apparent disruption on this structure is assumed to indicate transmural inflammation, which is
considered as a hallmark of CD.
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Note that most of these earlier studies on OCT for lower GI applications have been
focused on inferring information from cross sectional images. However, as it has been seen
throughout this section, en face visualization is critical in order to identify pit patterns, vascular
changes, flat or depressed lesions, and other diagnostic features relevant to lower GI diseases.
However, tied to the technological challenges in the development of OCT probes that can
acquire a volumetric data from which an image can be reconstructed in an en face fashion, as
well as limitations in achieving fast imaging speeds have been so far obstructed the use of OCT
for many of the lower GI applications that require the identification of the aforementioned
features.
On the other hand, in the recent years there have been many advances in both OCT
technology and instrumentation. Recently, a study by our research group has demonstrated in
vivo endoscopic OCT images from lower GI tract that clearly showed features of regular crypt
architecture (Type - I pit pattern) [167]. This study employed a Fourier domain mode locked
(FDML) laser with a tuning range of 180 nm, achieving an axial resolution of 6 um in tissues over
a 180 mm2 field with an imaging range of 1.6 mm. Furthermore, this study featured an OCT
probe which performed spiral scanning of the imaging beam, actuated proximal to the
endoscopists. However, due to the long length of the probe and anatomical constraints of the
human colon, such as the presence of sharp bends, makes it challenging to transfer the rotation
to the distal end uniformly. Hence, artifacts associated with this non-uniformity in the rotation
and other mechanical factors, such as frictions during the pullback, limits the reproducibility of
the spiral scan, degrading the quality of the enface images [168].
In the recent years several distally actuated probes have been developed to overcome the
challenge of non-uniform rotation for proximally actuated OCT probes. Examples include
micromotor, miroelectromechanical (MEMS) and piezoelectrical transducer (PZT) scanning
technologies [169-173]. Especially, a forward scanning PZT probe has the potential to generate
images resembling to confocal images with better contrast and signal to noise ratio (SNR),
without the need of external contrast agents [174]. Hence, with the integration of these novel
scanning technologies to the endoscopic OCT systems, it is expected that more studies will be
conducted in assessing the utility of OCT for lower GI applications. It is the author's belief that
in many of the clinical applications mentioned in this section, OCT can be used in conjunction
with a red flag technique, such as NBI or chromoendoscopy, in order to increase the yield of
detecting neoplastic changes and decreasing the errors due to random sampling, similar to the
clinical role of CLE. Moreover, OCT should outperform CLE due to its unique advantages such as
performing depth resolved imaging for upto 1-2 mm below the tissue surface, which will aid in
grading of neoplastic changes and enable the detection of submucosal invasion, enhanced
contrast due to the additional coherence gate to the inherent confocal gate, increasing the field
of view, ability to work non-contact to the tissue and eliminating the need of external contrast
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agents. Furthermore, incorporating Doppler OCT methods, it will be possible to extract
information related to the blood flow and enhance the visualization of the vessels and
capillaries, similar to the clinical utility of NBI that was previously discussed [175, 176].
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3. Prior Art in Optical Coherence Microscopy
3.1. Overview of OCM Imaging
As mentioned in the previous sections, OCM employs coherence gating in order to reject
multiply scattered light. With the use of broadband light sources, an axial resolution of <10 um
can be easily achieved, which is on the order of the thickness of histological slides and is argued
to be necessary for obtaining cellular resolution images [1]. For confocal imaging, on the other
hand, mainly the magnification of the objective determines the axial resolution of the system.
The practical implication of having intrinsic high axial resolution for OCM imaging is that the
axial and transverse resolutions are effectively decoupled in the system, such that the
numerical aperture (NA) of the imaging objective can be reduced without losing axial
resolution. Reducing the NA will translate into larger depth of field where the unique advantage
of OCM, which enables depth resolved imaging, can be utilized to generate images from
multiple depths without the need for physically translating the focus [2, 3].
As an example, Fig. 1 depicts the dependence of confocal range and transverse resolution
to the NA of the objective at the 1060 nm and 1310 nm wavelengths. The confocal range is
defined as the two sided distance (Rayleigh range) where the beam diameter increases by a
factor of -v2, and transverse resolution is defined as the radius where the beam intensity
reduces to I/ e2 of its maximum value (lie2 spot size). The equations used to calculate these
two parameters are given in Section 4.1. A beam diameter of 8 mm and water immersion
objective is assumed for the calculations. From Fig. 1 (B) it can be observed that even for
moderate NAs (< 0.4) a resolution better than 3 um can be achieved. On the other hand, the
dependence of confocal range on the NA is more drastic as it scales inversely with the square of
the NA. Hence to achieve cellular resolution solely by confocal imaging an NA > 0.8 is required.
However, with OCT one can readily achieve cellular resolution with the coherence gate,
eliminating the need for high NA objective to provide cellular axial resolution. Furthermore,
lower NA imaging also enables to obtain images from deeper regions of the sample, as the
multiple scattering effects would be reduced when the focus is translated into the sample [4].
Therefore, for OCM applications the NA of the objective can be selected to provide a desired
transverse resolution and field of view, without consideration about losing the axial resolution.
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Figure 1: Dependence of confocal range (A) and transverse resolution (B) to the NA of the
objective for two different wavelengths.
Next sections give an overview for the history of development of OCM systems, with a
particular emphasis on their clinical applications. Similar to the developmental stages of OCT
technology, OCM also evolved from time domain techniques to spectral domain and swept
source imaging methods. The sections are divided into three categories based on these imaging
methods, which will closely follow the development of the OCM technology. Discussion for the
differences between these three techniques is also included outlining the advantages and
disadvantages of each imaging method. An in depth theory about OCT and OCM will not be
presented in this thesis. Readers are directed to some of the excellent book references that
discusses the mathematical background of OCT and OCM imaging [5-7]. Moreover, there are
also high quality, published doctoral dissertations that provides a solid background on the
technical aspects of OCT and OCM imaging [8].
3.2. Time Domain OCM
Time domain OCT methods have the well know sensitivity disadvantage as they acquire images
from a single depth, whereas Fourier domain methods acquire images from the entire depth
range simultaneously [9]. Moreover, when cross sectional image needs to be generated, then
the reference arm path length should be mechanically changed, which restricts the acquisition
speed of the A-lines. These factors pose a serious limitation against the use of time domain OCT
imaging methods. However, for OCM applications, if the en face image is to be generated from
a single depth, then neither of these factors actually plays a decisive role. In fact, one can
generate en face images with a speed limited by the maximum speed of the scanners in the
system. For Fourier domain OCM, on the other hand, the axial scan (A-scan) rate is still a
limiting factor for the achievable imaging speeds.
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As previously mentioned, reference arm length is set to a fixed length for time domain
OCM. However, instead of scanning the reference arm length, a phase modulator is employed
in the reference arm in order to achieve a heterodyned optical signal. Note that, heterodyned
detection is proven to dramatically improve the SNR of optical imaging systems by achieving
nearly shot-noise limited detection [10]. Consequently, to generate time domain OCM images
the interferometric signal is detected using a balanced detector, which is then band pass
filtered and demodulated using either analog mixers or IQ-demodulators, or using digital filters
and mixers after the heterodyne signal is sampled by the acquisition card. Note that the
heterodyne frequency is typically on the order of 1-10 MHz, which is possible to acquire using
standard digitizers or acquisition cards.
First demonstrations of OCM are published within the first years following the invention
of the OCT technology [11, 12]. Note that in these studies, the phase delay in the reference arm
is achieved using a piezoelectric fiber stretcher, which restricted the heterodyne frequency,
consequently the imaging speeds, to a few kHz. This limitation slowed the development of real
time OCM systems for several years until the development of grating based phase/delay
scanners [13]. The next generation time domain OCM (TD-OCM) system employed this
approach to achieve a 1 MHz heterodyne frequency [14]. Using a broadband Ti:A1203 laser
centered around 800 nm, an axial resolution of 3 um is achieved, where the transverse
resolution is set to 2 um by underfilling a 40X objective. In vivo imaging of Xenopus laevis
tadpole and human skin from nailfold region has been demonstrated with this system.
Recently an integrated time domain OCT/OCM system have been demonstrated which
uses a combination of a low power objective (lOX) for OCT imaging and a high power objective
(40X) for OCM imaging [15]. As the light source it uses a Nd:Glass laser which is spectrally
broadened using a high NA fiber in order to provide an axial resolution of < 4 um. Moreover, an
electro-optic waveguide modulator provides a phase modulation of 1 MHz for the reference
arm light. Note that, for the OCT imaging mode, the reference arm length is scanned to
generate cross sectional images. In this study images of ex vivo samples from the human GI
tract is presented, which showed close correspondence to the histological appearance of these
specimens [15]. Using the same system, several other ex vivo imaging studies have been
conducted on different pathologies from various human tissues such as thyroid, breast and
kidney [16-18].
3.3. Spectral/Fourier Domain OCM
Spectral/Fourier domain OCT (SD-OCT) systems employ a spectrometer in order to record the
light spectrum corresponding to each transverse position (A-line) on the sample. Reflections
from the sample are coded in the spectrum as a sinusoidal function in wavenumber. Hence,
Fourier transformation of the spectrums produces the depth scans. The detector for the SD-
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OCT systems is typically a line scan camera that records the spectrum of a single A-line. Hence,
maximum line acquisition rate achievable by the camera typically sets the A-scan rate of the
imaging system. Furthermore, conventional line scan cameras employ CCD or CMOS detectors,
which are sensitive upto NIR wavelengths (< 1000 nm). Therefore, SD-OCT systems typically
utilize a light source with a spectral band centered around 800 nm, where the water absorption
and sample scattering is relatively small, and the camera still has a reasonable detection
efficiency. For OCT applications, the sensitivity advantage of Fourier domain detection, as well
as the dramatic increase for the imaging speed due to obtaining entire imaging depth from a
single A-scan, caused a rapid shift in the OCT technology as SD-OCT replaced TD-OCT
applications.
For OCM applications, the utilization of NIR light around 800 nm also opens the possibility
of implementing an integrated OCM and multiphoton microscopy (MPM) system in order to
simultaneously achieve molecular contrast. Note that for most of the intrinsic as well as
extrinsic contrast agents employed in two photon (TPM) and second harmonic generation
(SHG) microscopy systems, the excitation wavelength is typically around 700 - 850 nm range,
whereas the emission wavelengths are typically around UV regime (300 - 550 nm), making it
possible to use single light source for excitation for MPM as well as for SD-OCM imaging [19].
Consequently, some of the initial SD-OCM studies have employed integrated OCT and MPM
imaging.
In one study by Vinegoni et al., a Ti:Sapphire laser centered at 800 nm with a bandwidth
of 60 nm has been employed to generate simultaneous SD-OCM and MPM images with 4.7 um
coherence gate, 2.2 um confocal gate and 0.9 um transverse OCT resolution over a 600 um x
600 um field of view at a 29 kHz A-scan rate [20]. Using an extremely high power objective (NA
= 0.95), OCM and MPM images from fibroblast cell cultures have been demonstrated with very
fine cellular and molecular detail. In an extension to this study, spectrums obtained from
different regions of single cells are processed using light scattering spectroscopy (LSS)
techniques, in order to enhance contrast of the OCM images [21]. Confirmed by the
corresponding MPM images, where a nuclei specific stain is employed, this study clearly
showed that for imaging of singular cells, regions occupied by cell nuclei produces spectral
oscillations consistent with the predictions of Mie theory [22]. However, this effect was less
pronounced when the bulk tissue excised from a rat muscle was analyzed with the same LSS
analysis method [21]. In another study with combined SD-OCM and MPM system, mean
scattering intensity and scattering area from different organelles have been quantitatively
measured and it has been found that the scattering from nuclei is actually more than a factor of
2 smaller than the scattering from other organelles such as mitochondria and actin filaments
[23]. Nevertheless, these studies demonstrate another advantage of Fourier domain detection
over TD-OCM, where spectrums can be processed to enhance the contrast in OCM images.
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Another advantage of SD-OCT and SD-OCM systems are the very high phase stability of
the imaging setup. Especially when a common path interferometer is employed, where the
reflection from the cover slip surface acts as the reference arm signal, an extremely high phase
stability of a few milliradian can be achieved. This phase stability of SD-OCM systems can be
exploited to achieve phase contrast imaging as well as to provide sub-micron accuracy for
measuring displacements in the living cells or tissues. Indeed several SD-OCM studies have used
this approach to generate phase contrast and functional images and measuring variations in the
optical path lengths as small as 2 nm [24-27]. The ability of measuring phase of the back
reflected beam also opens the possibility of numerical algorithms to correct for aberrations or
the defocusing effects on the OCM images. An extension of this approach is employed in
interferometric synthetic aperture microscopy (ISAM), which provided isotropic transverse
resolution by numerically extending the depth of focus upto 1 mm even when a high NA
objective is used in the imaging setup [28-30].
There are also several studies that used hardware based approaches to extend the depth
of field of the SD-OCM images. Using a specially designed Axicon lens it is shown that it is
possible to have a nearly constant transverse resolution of 1.5 um along a focal range about
200 um, which represents an increase in the depth of focus by an order of magnitude [31].
Another approach to extend depth of focus is to apodize the central portion of the collimated
beam incident onto the back focal plane of the objective, which results in a bessel-gaussian
beam around the focal plane. Using this method a SD-OCM system has been recently
demonstrated which achieves about 2 um transverse and 1 um axial resolution along the first
300 - 400 um depth of the tissue [32]. Imaging of ex vivo human and swine coronary samples
have been demonstrated in this study where cellular features and single cell organisms such as
lymphocytes, monocytes and macrophages were identifiable in the resulting cross sectional
OCT images. Here it should be noted that both of these methods for depth of field extension
sacrifice sensitivity as the main lobe of the resulting gaussian-bessel beam contain only a
fraction of the total energy [33]. The loss of sensitivity is typically on the order of 10 - 20 dB,
depending on the depth of field extension that will be achieved, which is detrimental especially
in an in vivo imaging setting as one cannot increase the light exposure to account for the loss of
sensitivity. For ex vivo OCM imaging, on the other hand, incident light power can be scaled or
several volumes from the same region can be averaged to counteract the loss of sensitivity.
Furthermore, the unique advantage of Fourier domain detection which acquires images
from the entire depth range also allows for correcting of the curvatures in the scan field caused
by the non-telecentricity of the imaging configuration as well as the aberrations of the objective
lens. In the literature several SD-OCM studies have been demonstrated correction for this
effect using a calibration field (notice that a detailed description on this phenomenon and
methods on how to correct for it will be given in Section 4.8) [34, 35]. Consequently, using an
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integrated SD-OCM and MPM system, in vivo cellular resolution images from human skin have
been demonstrated [35, 36].
3.4. Swept Source/Fourier Domain OCM
In swept source/Fourier domain OCT (SS-OCT) systems, at any given instantaneous time only a
narrow band of the full spectral bandwidth is incident on the sample. By mechanically changing
the cavity length of the light source, this spectral band is swept across the full bandwidth of the
spectrum as a function of time. Therefore, the rate which the instantaneous linewidth scans the
spectrum sets the imaging speed (A-scan rate) for SS-OCT systems. For SS-OCT systems, a high
frequency photodetector followed by a digitizer card is used to acquire spectrums as a function
of time. Note that, the availability of photodetectors for the IR range opens up the possibility of
utilizing light sources at 1 um as well as 1.3 um, which have less scattering and increased
penetration depth compared to using a spectral band around 800 nm [37, 38].
The SS-OCT technology is gaining increasing acceptance in the OCT community as the scan
rates achievable with it exceeds the line rate of the cameras employed by the SD-OCT systems.
Using a swept source, Fourier-domain mode-locked (FDML) laser, an A-scan rate of upto 5.2
and 1.37 MHz has been demonstrated at 1.3 um and 1 um, respectively [39, 40]. Note that the
current state of art line scan cameras can provide A-scan rates at most 300 kHz, which limits the
maximum achievable scan rate of the SD-OCT systems.
Application of OCM with a swept source light source (SS-OCM), on the other hand, has not
been utilized widely so far. One reason for this is the non existence of high speed swept source
lasers until recently, which occluded real time imaging. Moreover, compared to light sources
employed in SD-OCT systems, achieving broad tuning range for the swept source light sources
operating at 1 um and 1.3 um is more challenging, which limits the axial resolution of the
imaging system. Although there is no definitive consensus on this subject, it has been argued
that an axial resolution of < 5 um is required for achieving cellular resolution imaging in highly
scattering biological samples, which necessitates a tuning range of > 150 nm for longer
wavelengths [1]. Upto date a swept source light source which exhibits both high speed and
broad tuning range was not existent.
In one of the few SS-OCM studies in the literature, an FDML laser with a tuning range of
110 nm has been employed, which operated at 42 kHz [41]. Using an objective with effective
NA of 0.35, a transverse resolution of 1.6 um and axial resolution of 8 um has been achieved in
tissue. In this study, in vivo cellular images of Xenopus laevis tadpole as well as fixed rat kidney
and images from ex vivo human colonic tissue have been demonstrated. In another study a
binary phase spatial filter is employed in order to extend the depth of focus of the SS-OCM
system by a factor of 10 [42]. This system used a modified version of a commercial SS-OCT
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system as the light source which worked at 16 kHz. Note that as discussed in the previous
section, the use of Bessel beams caused a reduction about 20 dB in the sensitivity of the OCM
system. In the same study, images from microsphere phantoms have been shown to illustrate
the extended depth of focus of the system.
Recently, a new technology for generating wavelength swept light source, named as
micro-electro-mechanical systems (MEMS) tunable Vertical-cavity Surface-emitting Laser
(VCSEL), has been adapted for OCT imaging [43, 44]. Due to its extremely small cavity length of
a few mm, this laser has the unique feature that it exhibits extremely long coherence length,
hence the fall off on the sensitivity with respect to increased path length difference, typically
seen in SD-OCT and SS-OCT systems, are not observed through the whole imaging range (note
that that there might be still some fall off due to decreased detector response at higher
frequencies). Recently our group have shown the first demonstration of this technology in
ophthalmic imaging achieving a variable sweep rate from 60 kHz upto 1.2 MHz [45]. Note that
this laser also has the advantage of being very compact, which is an important factor if the
system needs to be employed in a clinical setting, such as pathology laboratory or endoscopy
suite. Furthermore, newer generation of VCSEL lasers have expected to achieve a broad tuning
range of 160 nm at 1.3 um, which will achieve an axial resolution of < 5 um.
3.5. Comparison of OCM Imaging Methods
In the previous sections a general overview and literature review of several OCM imaging
methods has been presented. Some of the key concepts of the respective imaging modalities
will be re-iterated here in order to put the discussion into perspective.
TD-OCT has been replaced by the Fourier domain imaging methods in the state of the art
applications of OCT, mainly due to the speed and sensitivity disadvantage of this technique.
However, for OCM these two main factors do not play a dissuasive role. In fact, the speed of
OCM for acquiring en face images is still faster than either SS-OCM or SD-OCM, because the
heterodyne modulation frequency that can be used by the former modality is higher than the
current A-scan rates achievable by the latter techniques.
On the other hand, these advantages of TD-OCM methods are offset by the limitation of
not being able acquire images simultaneously from several depths. As it has been discussed in
Chapter 2, being able to visualize depth dependent features are significant for grading as well
as determining extend of invasion or the neoplastic progression. Moreover, this property also
enables to correct for the curvatures in the scan field as will be seen in Section 4.8.
Furthermore, obtaining spectral information opens up the possibility of using numerical
techniques to correct for dispersion, aberrations or defocusing effects, as well as to enhance
the contrast of images or extract quantitative information related to the composition of the
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tissue, such as nuclear size and density. Due to these unique advantages of Fourier domain
imaging methods, it is the author's content that SS-OCM and SD-OCM will replace TD-OCM
imaging, parallel to the evolution of OCT applications.
As for the comparison of SD-OCM and SS-OCM techniques, it can be observed that
majority of the current OCM systems are utilizing the former method. This can be argued to be
mainly related to the unavailability of high speed, broad band swept source light sources.
Furthermore, even if the A-scan rate of SD-OCM system is not as fast as the SS-OCM system,
this was not perceived as a limiting factor as the imaging speed for an ex vivo application is not
considered as critical as it is for in vivo imaging applications, where in order to prevent motion
artifacts it is certainly crucial to acquire images with high frame rates. However, for the
translation of the OCM imaging to endoscopic applications, as well as for the scenario where
OCM provides real time feedback for intraoperative guidance, imaging speeds will still be
demanding. Furthermore, acquisition of the spectrums only require the use of a photodetector
and acquisition card, which is more convenient for a clinical setting as opposed to the
requirement of a precisely aligned spectrometer for the SD-OCM systems.
The development of VCSEL technology and its application to OCT imaging opens up new
venues where very simultaneously high speeds (> 1 MHz) and broad tuning ranges (> 150 nm)
will be achievable with a SS-OCM system. Moreover, the small footprint of the light source is
especially useful for building a portable system that can be used in the pathology laboratory or
in a GI suite. For these reasons, in the course of the project which this thesis is based on, it has
been decided to explore the utility of the VCSEL light source for the OCM application.
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4. Swept Source OCM System Development and Characterization
4.1. Sample Arm Design
Figure 1 depicts the sample arm design employed in VCSEL OCM system. This design consists of
a collimator lens (f, = 11 mm), a compound scan lens (f, = 37.5 mm), a compound tube lens (
f = 86 mm), an objective lens (f,), and a pair of galvanometer scanning mirrors in order to
raster scan the beam in the two transverse directions. The combination of the focal lengths for
the collimator, scan and tube lenses, and objective sets the magnification of the imaging system
and the resulting transverse resolution, confocal range and field of view.
DWmIAxla Scanmft
3.1mm afinmatd ewn 100
(N= . (CambrklgeTC
6210H-6mmmrror)
±4.2mm plase Kman 
f1= 11mm,dl = 0.5" tuebbe le * 10
(0 HPUCO-23- scmsj
02 = 75mm, d2 = 2"
MfhCiftlcso7c) f =37.5
4- 15mmd=2"fC ffhorlmls AC50CI5C)
Raster Plane
....... ................ ............... (± 4.6mm Scan)
N'4 - 15mm,64 = 2"1
(ThortsbeaMc50S-150C) . =86 mm
f5 - 200mm,d5 - 2"
(Thorlibs LE1015-C)
7.1 mm collimated
beam iameter
at the objectiv } o
Figure 1: Sample arm design with representative components, beam and scan sizes, for the
1310 nm VCSEL OCM System. For the sample arm of the 1060 nm VCSEL system, the
collimator is replaced with a collimator designed and coated for the respective wavelength
(Thorlabs TC12APC-1064), which nevertheless has the same focal length. Note that the scan
and tube lenses work with good performance for both 1060 nm and 1310 nm wavelengths,
hence they are employed in both systems. The scanning mirrors employed in this system are
analog galvos with a 6 mm mirror diameter (Model 6210H, Cambridge Tech, Bedford, MA).
The beam sizes and scan ranges are also included in Fig. 1, which are calculated assuming
a 1310 nm light source. For calculating the collimated beam size, the formula
d = 2f, tan (sin-'(NA))is used where an NA of 0.14 is used for the SFM28 fiber used for the
1310 nm system and for the H11060 fiber used in the 1060 nm system. The beam angle scans
the back focal plane of the objective with a magnification set by the ratio f / f. The 1/ e2 spot
size (wo) incident on the sample can be calculated using Af0 /d0, where 2is the center
wavelength of the light source and d0 is the collimated beam diameter after it has been
magnified. The focal length of the objective can be found by dividing the reference tube length
of the objective to the magnification of it. For instance, the reference tube length for the
Olympus objectives are 180 mm, which means that the effective focal length of the 40X
objective would be 4.5 mm. For the Zeiss objectives, on the other hand, the reference tube
lengths are 165 mm. The FWHM spot size can be calculated from coo by using the scale factor
1.175. Note that coo can also be calculated by finding the magnification from the fiber tip to the
focal plane of the objective, however, in order to find the collimated beam diameter and the
scan angles it is more convenient to use the formulas given here. Finally, the confocal
parameter, which is defined as the two sided distance where the beam diameter increases by a
factor of VT2, can be calculated using 2 [1]. The field of view can be calculated by noting
that the scan on the raster plane will be ±6.6 mm (f, tan($)), when the scanning mirrors
perform a ±10 degree scan (# = 10). This scan is then demagnified by a value given by the ratio
of focal lengths of the tube lens and the objective.
Table 1 gives the theoretical calculations for spot size, confocal parameter and field of
view for three objectives that is identified to be suitable for this project. These objectives are
water immersion which will reduce back reflections from the objective-cover glass surface.
Furthermore, compared to regular objectives used for light microscopes that have less than
30% transmission at longer wavelengths, the objectives selected here also have reasonably
good throughput at 1.3 um (~50%).
Objective
Zeisslox -W 0.3 16.5 3.04 3.5 44 2500
Zeiss20x - W 0.5 5.25 1.52 1.79 U1 1250 131 nu
Olmpus40x-W 0.8 4.5 0.53 0.96 3.3 775
Zeisslox - W 0.3 16.5 2.72 3.2 43.9 2500
Zeiss2Ox - W 0.5 5.25 1.36 1.6 11 1250 1060 nm
OlmIpus40x -W 0.5 4.5 0.74 0.57 3.25 775
Table 1: Theoretical spot sizes, confocal parameters and field of views for three different
water immersion objectives for 1060 nm and 1310 nm wavelengths. Part numbers of the
objectives are: Olympus 40X - LUMPLFL 40XW/IR2, Zeiss 20X - N-ACHROPLAN 420957, and
Zeiss 1OX - ACHROPLAN 440039.
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The scan and tube lenses essentially image the back focal plane of the objective onto the
scanning mirrors. However, as there is a physical distance between the two scanning mirrors,
the back focal plane can not be imaged onto the two scanning mirrors simultaneously with this
imaging configuration. This imaging setup is termed as non-telecentric, which causes the scan
field to be curved at the focus of the objective. Note that, it is possible to design a telecentric
microscope using two separate scanning mirrors and putting relay lenses in between, hence to
image the back focal plane of the objective precisely to both of the mirrors. However, this
approach did not pursed here, as it will make the system more bulky, cause additional light loss
and will make the alignment more challenging. All these factors are undesired if the system is to
be used in a clinical setting. Furthermore, as it is mentioned previously, it is possible to correct
for this scan field curvature in the post processing as will be seen in Section 4.8, which marks a
significant advantage of Fourier domain detection methods as opposed to timed domain OCM
applications.
The sample holder depicted in Fig. 1 is a modified cassette used in standard histological
processing, in which a cover slip has been mounted on its top to provide an imaging window. A
tissue embedding sponge is put below the sample which helps to press it to the cover glass in
order to provide a flat surface for the imaging. After imaging is performed, sample can be fixed
into formalin and transported directly to the histological processing without the need of
removing from the cassette. This will ensure corresponding fields to be visualized for the OCM
images and for the H&E slides.
4.2. Reference Arm and Interferometer Design
Schematic of the internally clocked 1310 nm VCSEL OCM system is shown in Fig. 2. The light
source is a 1310 nm swept source VCSEL laser, which is routed either to the MZI arm or to the
imaging arm. In the MZI arm, a fringe signal from the middle of the imaging range is recorded,
which is used to calibrate subsequent spectrums as described in Section 4.6. In the imaging
arm, light is divided into the sample and reference arms using a fiber coupler. Note that,
reference arm has a single pass design which necessitates a fiber spool or an extra fiber coupler
to be inserted into its path in order to match the fiber lengths between the sample and
reference arms. The glasses put into the reference arm provide dispersion matching due to the
extra optical components in the sample arm. Note that, due to single pass design of it, double
amount of the glass as there is in the sample arm needs to be inserted to the reference arm,
which potentially might necessitate 20 - 30 cm of glass. Instead, the fiber length of the
reference arm is made longer than the sample arm in order to account for some of the
mismatch in the optical path.
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Figure 2: Schematic of the VCSEL OCM System. DAQ: Data acquisition card (Alazar 500 MHz -
ATS9350, AlazarTech, Pointe-Claire, QC). DMG: Dispersion matching glass. IA: Iris attenuator.
The balanced detector employed in the system is a prototype from Thorlabs which has a
bandwidth of 200 MHz.
An iris attenuator is inserted to the reference arm in order to attenuate the excess light.
Note that due to high noise rejection of the balanced detector, a reference arm light < 20 uW is
usually sufficient, hence the light passing through to the reference arm needs to be attenuated
significantly. It has been observed that iris attenuator is a better choice than variable ND filters
typically used in the SD-OCT systems, as the small thickness of the ND filter causes extra
reflections in the images, especially with the long coherence range of the VCSEL laser.
4.3. Light Sources and Other Hardware Components
The 1060 nm OCM system uses a prototype turnkey VCSEL light source from Thorlabs, which
run with optical clocking. This VCSEL module had internal wavelength and power sensors to
detect and adjust sweeping behavior of the laser, hence did not require manual adjustment to
operate. Therefore, the design only included the imaging arm of the system depicted in Fig. 2.
This system worked at an A-scan rate of 100 kHz (sweep rate = 50 kHz). The output power of
the light source is ~ 15 mW. The laser produces a sweep with 80 nm tuning range centered
around 1060 nm.
The 1310 nm VCSEL source, on the other hand, produces a sweep with a 120 nm tuning
range with an output power of ~30 mW. A signal generator is connected to the input of the
MEMS circuitry of the light source, which produced a sinusoidal waveform to drive the laser
cavity. The amplitude and offset levels of the waveform is carefully adjusted to adjust the
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tuning range to its highest value while preventing snapdown of the cavity. For this system a
sweep frequency of 280 kHz is used, which is the resonance frequency of the VCSEL and
therefore ensures the laser to work in the most stable region and gives the broadest tuning
range. Since the sweeps are double sided, with a 280 kHz driving frequency the effective A-scan
rate of the system is 560 kHz, which is faster by a factor of 5 compared to the state of the art
commercial swept source lasers. Furthermore, by sacrificing some of the tuning range and
stability it is possible to run the laser off resonance and achieve even faster imaging speeds.
The data acquisition card used in both of the OCM systems is a 500 MHz card from
AlazarTech (Pointe-Claire, QC). It has two input channels, which can be operated
simultaneously by reducing the effective sampling rate of each channel to half (500 KS/s). It has
a 12 bit depth for both of the channels, and can digitize from ±40 mV upto ±4V. It supports
external clocking, which is critical to implement optical clocking, and allows a clock frequency
upto 500 MHz. It requires a clock input of at least 200 mV for external clocking. It also has a
trigger input which allows the synchronization of the laser sweeps with the acquisition of the A-
lines.
Both of the 1060 nm and 1310 nm systems also employ an analog 1/O card (NI PCI-6751,
National Instruments, Austin, TX) for driving the scanning mirrors, as well as for synchronization
purposes explained in Section 4.4. This card supports 4 analog outputs at 16 bit depth and also
has an input channel allowing for external clocking.
The 1310 nm OCM system is used both with internally clocked mode, which required the
MZI fringes for calibration, and with optically clocked mode. For optical clocking a small portion
of the VCSEL output is constantly fed to the MZI arm depicted in Fig. 2. Then the analog MZI
signal which had a nearly gaussian envelope is converted to an optical clock signal with equal
amplitude using a Thorlabs prototype pulse shaper and sent to the external clock input of the
DAQ. Optical clocking ensures the fringes to be sampled equal in wavenumber and does not
necessitate an additional calibration signal. Details on this process are explained in Section 4.6.
Note that, the frequency generated by the path length difference in the MZI arm sets the
maximum imaging depth of the system. As a 500 MHz DAQ (ATS9350, AlazarTech, Pointe-Claire,
QC) is employed in the system, the clock frequency is set to about 400 MHz in order to avoid
overclocking of the card as well as the match the bandwidth of the dual balanced optical
detector. However, as the fringe frequency is not linear, 400 MHz is actually the maximum
frequency of the fringe whereas the average frequency of it is about half of that value.
Therefore, with optical clocking one effectively uses about half of the imaging range can be
achieved using fixed internal clocking. However, this is not a limiting factor for OCM
applications as an imaging range of a few mm achievable with optical clocking is usually
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sufficient. Moreover, for most of the acquisition cards it is possible to use higher clocking
frequencies and overclock them.
4.4. System Synchronization
In a swept source OCT system, there are several components that need to be synchronized in
order to perform a smooth acquisition. Here, an outline will be given that describes how the
synchronization is achieved for the 1310 nm VCSEL OCM system. For the 1060 nm system,
synchronization was already established with the turnkey operated prototype VCSEL source and
the imaging engine.
To give a general overview, the electronics part of the system can be divided into several
modules. One component is the light source which generates laser sweeps at a frequency set
by the waveform that drives the MEMS cavity. The second component is the data acquisition
card (DAQ) that performs the acquisition of the fringe samples at its internal or external clock
frequency. One task for the synchronization would be to acquire a certain number of samples
for each sweep of the laser, ensuring that the acquisition of each fringe starts from the same
wavelength. A third component of the system is the 1/0 (NI) card, which produces the
waveforms to drive the scanning mirrors, as well to synchronize acquisition of each B-scan to
the beginning of the fast galvo trajectory.
Figure 3 depicts the general synchronization scheme. The light source outputs a square
signal (laser trigger) at its sweep frequency, which is about 280 kHz for the 1310 nm VCSEL laser
when operated at resonance. This signal can be taken from the synchronization output of the
waveform generator that drives the laser. Then, this laser trigger is sent to a pulse generator
(TGP110, TTi), that adjust the delay of the incoming square wave in order to match the start of
the sweep to the start of the A-scan, which is done by observing and centering the mirror
fringes in the preview mode. For each B-scan, the NI card outputs a square wave consistent
with the length of the B-scan duration, as well as a slowly rising ramp and sawtooth signals for
the slow and fast scanning mirrors, respectively. This square wave is then combined with the
laser trigger signal using a logical AND gate, which is then sent to the trigger input of the data
acquisition card. The purpose of this step is to synchronize the start of the B-scans with the
acquisition, as the card will start the acquisition of the particular B-scan after it receives the first
trigger signal overlapping with the B-scan duration signal. For each rising edge of the trigger
signal, the DAQ will acquire a predetermined number of points producing the fringe for that
particular sweep. Moreover, the laser trigger signal is also sent to the clock input of the NI card,
in order to clock the card with the exact frequency that the laser is sweeping. This step will add
an extra degree of synchronization accuracy.
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Figure 3: Schematic Representation of the System Synchronization. The high frequency square
wave signal corresponds to the sweep trigger, whereas the low frequency signal corresponds
to the B-scan duration signal. Acquisition will be performed for the duration of the B-scan,
corresponding to the overlap between the laser trigger signal and the B-scan duration signal,
shown by the red color.
The procedure described in this section ensures a synchronized acquisition. However,
there are still some mechanical delays between the signal that is sent to the scanning mirrors
and the actual starting time of the movement of the mirrors. This causes a few pixels of
artifacts in the beginning of each B-scan, until the scanning mirrors actually start to follow the
input waveform, which can be readily removed in the post processing by cropping the related
portion of the image.
4.5. Signal Processing Scheme for Generating OCT and OCM Images
The processing scheme for generating cross sectional OCM images follows standard techniques
described in the literature in great extend and will not be explained in detail here, however, a
brief summary will be presented [2]. A general flow chart for the processing of the spectrums is
given in Fig. 4.
If the spectrum is acquired without optical clocking, then the wavenumber calibration
step described in Section 4.6. will be performed. Next, the background spectrum is subtracted
from the acquired spectrum which is calculated by averaging the spectrums acquired when the
beam is scanned off the sample. This step will remove fixed pattern noise common for the
sample and reference arms. The average background can be further smoothed using a median
filter and divide the background subtracted spectrums. This step will remove any residual DC
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Perform A-k calibration by spline resampling *
Subtract average background spectrum
Divide to smoothed background spectrum
Dispersion Compensation
Perform Spectral Reshaping **
Take FFT
Figure 4: Processing Flow Chart to Generate OCT Images. The step denoted with * is
performed only for the spectrums acquired without optical clocking.
artifacts on the spectrum caused by the imbalances of the detection. Next, the spectrums will
be multiplied with a phase term to correct for dispersion. The calculation of this phase term for
the dispersion is explained in detail in Section 4.6. Finally, spectrums are reshaped using a
gaussian or other smoothing window, in order to reduce side lobes. Note that this step will
reduce the axial resolution with a severity depending on the type and size of the selected
window as can be seen in Section 4.9. Hence, it can be skipped if highest axial resolution is
desired on the images. The final step consists of taking the Fourier transform of the reshaped
spectrums, generating the cross sectional OCM image. Note that, depending on the sample rate
and the sweep rate of the light source, the number of pixels on the acquired fringe can be
small. For instance, for the optically clocked system working at 280 kHz sweep rate, there are
about 357 samples on each fringe. Due to small amount of pixels in the acquired spectrums, it
will be useful to zero pad the spectrums and take the FFT afterwards in order to increase the
pixel density. As an example, for a total imaging range of 1.5 mm; taking a 2048 points FFT will
give a pixel density of 1.5/1024 = 1.5 um/pixel on the resulting images, which is enough to have
sufficiently sampled images (note that in order to be critically sampled the sampling density
should be at least twice the axial resolution of the system). Table 2 summarizes the acquisition
parameters for the 1060 nm and 1310 nm systems. Due to the high sampling rate of the
internally clocked 1310 nm system and due to the lower sweep rate of the 1060 nm system, the
number of samples in the sweeps are relatively high, relaxing the need for upsampling of the
fringes.
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Number of
Operating Sweep Clock Samples per
Mode Frequency Frequency Sweep (single
sided)
1060 nm Optical Clock 50 kHz ~340 MHz 3400
1310 nm Internal Clock 280 kHz 500 MHz 890
1310 nm Optical Clock 280 kHz ~200 MHz 357
Table 2: Acquisition parameters for the 1060 nm and 1310 nm VCSEL OCM systems.
After cross sectional OCM images are generated, one can select a depth of interest and
construct the enface OCM image from this depth. Moreover, several depths can be averaged to
reduce the speckle of the images, at the expense of losing axial resolution, or projection views
can be generated by finding the average, maximum intensity, minimum intensity etc. images
along the entire depth. Moreover, color maps on the OCM images can be adjusted to provide a
desired appearance as will be discussed in section 4.8.
4.6. Considerations for Acquisition and Calibration of the Spectrum
A major feature of most SD-OCT and SS-OCT systems is that the wavelength characteristics of
the acquired spectrums are typically a function of wavelength (A). For instance, due to the
diffraction laws of light, the diffractive or reflective grating used in the spectrometer of the SD-
OCT system disperses light to the detector such that pixels are equispaced in wavelength (linear
in A). Similarly, the cavity of an SS-OCM system is swept such that each consecutive sample that
the detector acquires is a function of wavelength depending on the waveform that actuates the
laser cavity. As it is also the case with the VCSEL sources used in this study, usually a sinusoidal
waveform is employed for this purpose due to the resonant characteristics of the cavity,
although there are studies that used more tailored waveforms to linearize the sweeps [3].
On the other hand, the depth information is coded into the spectrums with a linear
dependence on wavenumber (linear in k). Hence, one has two ensure that the pixels of the
spectrum are linearly spaced in wavenumber prior to performing the Fourier transform
operation. In this project we have pursued two methods of accomplishing the task of sampling
the spectrum linear in wavenumber. The first method is based on using an external Mach
Zehnder interferometer (MZI) signal to acquire a fringe that has a single frequency component.
This fringe is then used to calibrate subsequent spectrums that are acquired. As the second
method, we will demonstrate that an optical clock derived from the MZI signal can be used
instead of the internal clock of the data acquisition card, which subsequently will allow the
acquisition of spectrums that are intrinsically linear in phase (wavenumber). These two
methods will be compared to each other and it will be seen that optical clocking is a superior
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technique for the OCM application, allowing the acquisition of spectrums in a more stable
fashion.
i. Calibration Using Mach-Zehnder Traces
This method consists of acquisition of fringes using an MZI, which is guaranteed to have a single
frequency component. From this MZI signal, one can extract the phase of the fringe and
resample it such that the resulting resampled fringe will have linear phase. In the following
more insight into this algorithm will be casted.
Since the MZI has only a single frequency component, analytical representation of the
detector output is a pure phase term. Hence, for the angle of it one expects to see a well
behaved monotonically and linear decreasing term as: 4Ie-k1z^ = -jkAz, where Ie-i*^r is the
analytical representation of the detected MZI signal, I is the envelope of the light source and
Az is the length mismatch of the MZI arms. Clearly, this behavior is valid only when the
detector output is discretizated linear in wavenumber (k), which, as mentioned earlier, is
usually not the case. As an example, Fig. 5 (A) depicts the plot of the angle of the analytic
representation of an acquired MZI signal where a curvature on the phase can be observed due
to nonlinear sampling of the fringe signal. Similarly the frequency chirp can be appreciated in
Fig. 5 (B) due to the nonlinear behavior of the sweep. Hence the task is to resample the
acquired spectrums such that the resulting analytical representation of the signal would have
linear phase. In order to accomplish this, a linear fit to the original phase can be made (as
shown in Fig. 5(A) and the spectrum can be resampled based on this fit. The resulting
resampled spectrum will have a linear phase and uniform frequency that can be observed in
Fig. 5 (A) and Fig. 5 (C), respectively.
Consequently, the method of calibration of the nonlinearly acquired spectrums using an
MZI interferometer can be summarized as follows:
1. Acquire MZI signal by adjusting the path difference between two arms to an appropriate
delay.
2. Calculate the analytic representation of the MZI spectrum.
3. Find the angle of the analytical representation and fit a linear curve onto it. This fit can
be constructed by connecting the angle of the first and last samples with a straight line.
4. Calculate the coefficients for a cubic spline interpolator for resampling such that the
analytic representation of the resampled spectrums will have linear phase (cubic spline
interpolation is a good balance for the trade-off between computational speed and
accuracy).
5. Use the coefficients calculated in the previous step to calibrate the subsequent
spectrums acquired during the imaging session
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Figure 5: Phase of the analytic representation of the acquired MVZI signal and linear fit (A), as
well as original (B) and resampled spectrums (C). Fringes are obtained with the 1310 nm VCSEL
system.
It is worth mentioning some practical considerations for the steps outlined above. First of
all, the appropriate delay for the mismatch between the MZI arms should optimally be around
half of the imaging range. If it is too close, then there won't be many cycles in the fringe such
that an accurate determination of the phase can be made. If it is too deep, then one will start to
observe nonlinearities due to the limited bandwidth of the detector.
A good way to test the fidelity of the calibration procedure is to compare the point spread
function (PSF) of the resampled spectrum to the PSF obtained from the envelope of the
spectrum. The envelope of the spectrum can be obtained by multiplying the spectrum with the
inverse of the phase of its analytic representation. This will produce a zero phase signal
(envelope), unrelated to the sampling issues and dispersion mismatches. This envelope would
be the best possible PSF achievable with the system in terms of axial resolution. The task is to
obtain the same PSF after wavenumber calibration. For the spectrum which is used for
calibration it is expected that the PSF of the resampled spectrum and the envelope are exactly
same, as it is ensured that the phase of this spectrum would be linear during the calibration
process. This is indeed observed in Fig. 6 (A). Moreover, Fig. 6 (B) shows that the envelopes
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Figure 6: The PSF of envelope and the resampled spectrum for the MZI signal used for
calibration (A). PSFs obtained from the envelopes of different A-scans from the same location
(B). The resolution for this PSFs are about 13.2 um in air, where the 1310 nm VCSEL laser was
tuned to about 100 nm bandwidth.
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Figure 7: PSFs obtained from resampled MZI signals from two different depths (~300 um in (A)
and ~1.3mm in (B)). Spectrums are obtained with the 1310 nm VCSEL system.
from different A-scans at the same depth are more or less the same, although, a few urn
horizontal shift is evident. Moreover, Fig. 7 depicts the PSFs acquired by moving the MZI to two
different depths, where one of the spectrums at the same depth as the spectrum whose PSF is
given in Fig. 7 (B) is used as the calibration. From Fig. 7 (A) it is evident that the PSFs do not vary
a lot at the shallow depth ranges. However, a considerable variation of the PSFs can be
observed in Fig. 7 (B), which is around the middle of the depth range of the imaging system.
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This variation is linked to the fluctuation on the sweep characteristics of the light source, in
which each sweep starts from a slightly different position.
A second point to consider is that, for the actual imaging arm (sample + reference arms), it
is very important that the total fiber and electrical cable lengths are matched to those in the
MZI arm. For the case where there are mismatches, one will see a broadened PSF, especially
when the path length difference of the MZI is different from the depth where the calibration
signal is acquired. Specific examples for this case will be given in the discussion for optical
clocking. One factor that complicates this issue is that a mismatch in the dispersion of the
sample and reference arms deteriorates the PSFs in a way similar to a mismatch in the cable
lengths of the imaging and MZI arms, and it is hard to decouple these two phenomena. Hence a
recommended procedure for matching the cable lengths of MZI and imaging arms can be given
as following:
1. Construct a sample and reference arm that does not have any elements in its path, and
measure the total fiber length in each arm to make sure that they are matched. This will
ensure that the dispersion in the sample and reference arms is matched.
2. Vary the optical and electrical cable lengths until the resampled PSFs are matched to the
PSFs obtained from the envelope at different depths. This way it is ensured that the
cabling lengths are matched between the imaging and MZI arms.
3. Switch to actual sample arm by inserting back the optics.
4. Match the dispersion of the system by putting glass to the reference arm until the
dispersion is matched between two arms. Again, the matching of the dispersion can be
determined by comparing the PSF of the resampled spectrum to the PSF of the
envelope. This way it is ensured that the dispersion of the system is compensated as
well.
When performing the steps outlined above, it is important that the fringe signal is
acquired close to the middle of the imaging range, since mismatches in the dispersion and cable
lengths make less effect for shallow depths as shown in Fig. 7 (A).
ii. Uniform Wavenumber Sampling with Optical Clocking
Although the wavenumber calibration using MZI traces works to some extent, it has several
disadvantages as shown in the previous section, mainly due to the variations in the sweeping
behavior of the light source. Note that, if the VCSEL source was run off-resonance in order to
increase its sweep rate, then it is expected for these variations to become even worse. One
possible method to overcome this issue is to simultaneously acquire MZI signals during imaging,
such that one has a corresponding MZI calibration trace for each A-line. However, this adds
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remarkable computational complexity to processing as one needs to calculate the resampling
coefficients for each individual A-line.
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each zero crossing of the MZI signal. Since the MZI signal is already a function of k , picking a
sample at each zero crossing will guarantee a sampling linear in k. This method is commonly
called as optical clocking, and has been to proven to increase the computational speed by a
factor of 2 to 10, as it circumvents the need for wavenumber calibration and oversampling of
the spectrum [4].
As shown in Fig. 8 (A), the phase of the spectrum acquired using a mirror as the sample
with the optically clocked system shows a linear behavior, as well as no frequency chirp is
observed if Fig. 8 (B). For comparison purposes with Fig. 5, a linear fit is made to this spectrum
and spectral resampling is performed as previously described. As shown in Fig. 8 (B) and (C),
original and resampled spectrums are almost identical, proving that optical clocking indeed
ensures linear sampling of the spectrums.
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For this project, optical clocking has been tested for the VCSEL source using a 500 MHz
Alazar data acquisition card (AlazarTech, Pointe-Claire, QC), and is confirmed to work more
reliably compared to the previous method of using single MZI trace for the calibration. To
maximize the portion of the MZI fringe used for clocking, a clocking circuit is used that converts
the sinusoidal MZI trace to a uniform amplitude square clock signal.
Figure 9 (A) shows an example of PSF found by taking directly the FFT of the acquired
spectrum compared to the PSF obtained from the envelope. A good agreement can be
observed between the two PSFs in terms of the FWHM and level of the side lobes. Notice that,
by adjusting the dispersion numerically, this PSF can be matched exactly to the PSF of the
envelope. Figure 9 (B) and (C) shows PSFs of the envelope and original spectrum, respectively,
for different A-scans. Comparing these plots to Fig. 7, one can appreciate the stability of the
spectrums with optical clocking due to the insensitivity of this technique to the drifts and
variations in the sweeps characteristics of the light source.
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Figure 9: PSFs obtained from the envelope and the raw spectrums acquired by the optically
clocked 1310 nm system proving the robustness of the acquisition scheme to the variations of
the sweep behavior of the light source. PSFs obtained from envelopes (B) and raw spectrums
(C) of different A-scans from the same location. (A) shows an overlap between these two PSFs.
System tuned close to its full 120 nm tuning range. Resolution measured as 11.6 um in air.
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As it is case for the calibration with MZI traces, for optical clocking it is also important to
match the cable lengths of the imaging arm and the MZI arm. To decouple cabling length from
dispersion, a similar procedure outlined in the previous section can be used. Again, it should be
kept in mind that the PSFs will be relatively insensitive to the variations of the cable lengths for
shallow depths. An example for this can be seen in Fig. 10, where the arm lengths are
mismatched by about 2 meters. For Fig. 10 (A), although some asymmetry in the PSF can be
observed, the resolution is still about the same as what was observed in Fig. 9. However, for the
PSF in Fig. 10 (B), which is taken from a longer delay, the broadening of the PSF is clearly
evident. Hence, it is important to perform dispersion compensation and cable length matching
for a long delay between the sample and reference arms, typically around the middle of the
imaging range.
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Figure 10: Effect of cable length mismatch on the PSFs from two different depths. Fringes are
obtained with the 1310 nm VCSEL system.
As a final point, if the cable lengths and dispersion of the system is perfectly matched,
then one expects to observe uniform resolution throughout the imaging range. However,
usually it is not possible to perform this degree of optimization due to the coupled nature of the
dispersion and cable lengths. However, it is still possible to compensate residual phase
variations numerically. For this, one can find the nonlinearity of the phase for a mirror
interference signal, and then use this phase to compensate for the phase nonlinearity of other
spectrums. Table 3 shows the axial resolutions of the optically clocked system for different
reference delays. In the first column a total of 1.6 um variation can be observed for the imaging
range when no numerical compensation is performed. For the second column, on the other
hand, the phase from the fringe at 350 um is used and the total variation is reduced to 1.2 um.
Notice that, the resolution progressively gets worse when the delay is further from the point of
calibration. For the last column of Table 3, the phase of the mirror near to the middle of the
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imaging range is used and one observes a variation less than 0.8 um for the imaging range.
Hence, a good choice for the mirror signal for its phase to be used for the calibration would be
to choose around the middle of the imaging range or around a depth where the sample is
expected to occupy.
Axial Resolution in Air (um)
Depth (ur) No dispersion compensation Using phase from Using phase from350 um 630 um
210 13.27 11.48 12.35
350 12.44 11.40 11.93
490 11.75 11.66 11.66
630 11.75 11.76 11.66
770 11.66 12.44 11.66
910 11.75 12.99 11.93
1050 11.61 12.71 11.61
Table 3: Axial resolutions (in air) for the optically clocked 1310 nm system at 120 nm tuning
range from different depths.
4.7. Generation of Large Field Images via Mosaic Imaging
Undoubtedly a major constraint of a high magnification imaging system is the limited field of
view (FOV). A method to overcome this limitation which is used in many clinical settings, such
as pathology, is to initially survey the specimen with a low magnification objective, then zoom
into region of interests by switching the objective with a higher power one using a turret.
However, there are cases when one wants to obtain high resolution images from the entire
surface of the specimen. As an example, for digitization of histology slides, one needs image the
slides in its entirety with high resolution. Another example would be that if one wants one to
one correspondence of the OCM images with the histology, then he will also be required to
image the whole specimen with a high power objective. Furthermore, in a clinical scenario
where the sample needs to be imaged in real time due to the integrity of the specimen, but it
will be interpreted at a later session, then it will be necessary to obtain images of the whole
specimen with a high resolution objective.
A method to overcome the field of view limitation of the OCM imaging system is to
acquire a number of small field images from different regions of the sample, and then combine
these images to generate a large field stitched image. Fortunately, this is a well known and well
studied research problem especially in the image processing community, and there are many
methods and algorithms that are developed in order construct seamless composite images by
combining individual frames [4]. Among many software that are developed to accomplish this
task, it is found that Image Composite Editor (ICE), which is a closed source but freeware
program from Microsoft, provides a reliable and robust environment for generating large field
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stitched images. After the stitching is completed, images can be converted to a deep zoom
format which produces a hierarchical format with different magnification levels. This format
can be opened using the HD View program from Microsoft which seamlessly allows user to pan
around the images and to zoom to regions of interests producing the native high resolution
view. Furthermore, the HD View program is integrated with the browsers allowing the user to
send the internet links of the stitched dataset or the specific views to satellite places,
eliminating the need for physically transporting large amount of data.
Figure 11 shows a demonstration of combining four small field images to generate a large
field mosaic image. The field of view for each image is about 500 um, and images are acquired
with a 50% percent overlap. Hence, the composite image has a total of 750 um by 750 um field.
Using an automated stage is it possible to acquire larger total fields, whose examples will be
presented later in the thesis. For generating the mosaic images, ICE performs a two step
process consisting of (1) alignment of frames within each other based on image features, and
(2) composition of the large field mosaic image by using several image blending algorithms such
as graph-cut optimization and gradient domain image-fusion algorithm, which accounts for
possible intensity and rotational variations between the overlapping fields [5, 6]. Note that the
images in Fig. 11 are acquired with a 50% overlap in order to ensure a seamless stitching by
providing more corresponding features between frames, however, if the contrast is high
enough then it is possible to have smaller overlap between the fields, which will decrease the
time required for the acquisition of the total field.
One major disadvantage of the acquisition of individual small field images is the long time
required for the total acquisition process. Here the limitation comes from the mechanical
movement of the translation stages, which has to perform a discrete movement after
acquisition of each individual frame. Especially if multiple depths are to be acquired by
translating the focus, then the total acquisition time can easily span 20-30 minutes, which is
impractical for a clinical setting. An alternative for acquiring individual square fields is to obtain
long strip images by disabling one of the scanning mirrors and continuously translating the
stage in the slow direction while acquiring the image [7]. Since the stage will only step after the
acquisition of one strip is finished, the imaging speed will be roughly limited by the scan rate of
the imaging system or the maximum frequency of the fast scanning mirror. In this setting, the
fast scanning mirror can be replaced by a resonant scanner to further improve the imaging
speed.
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Figure 11: Demonstration of large field of view generation by acquiring overlapping small field
images. Smaller field images are shown in (A). Arrows point to the direction of the stage
motion and dashed boxes show the overlapping regions. Resulting mosaic image is shown in
(B).
In addition to improving the imaging speed, strip imaging also has the advantage of
reducing the artifacts due to scan field and illumination non-uniformities, as the image of the
single scanning mirror can be placed directly to the back focal plane of the objective, which will
produce a flat scan field. One disadvantage, however, is that even for a very precise translation
stage, the motion parameters such as acceleration or the value of constant velocity is not
precisely same for a series of movements. Hence, due to these variations in the motion of the
stage it will be challenging to acquire the image of the same strip twice if one wants to acquire
and average several strip images. If averaging is not necessary, however, then strip imaging is a
good alternative to imaging smaller square fields. Initial tests demonstrated at least an order of
magnitude increase in the acquisition speed compared to the latter technique.
4.8. Image Processing and Display
i. Field Curvature Correction
In order to provide the compactness necessary for the OCM system to be put into a pathology
laboratory or an endoscopy suite, a non-telecentric sample arm design is employed as
described in Section 4.1. However, this comes at a cost of curvatures in the scan field, as the
back focal plane of the objective can not be imaged simultaneously to both of the scanning
mirrors. Figure 12 depicts an example of this phenomenon, where a mirror is used as the
sample. Figure 12 (A) and (B) are the cross sectional images generated by scanning the fast (X)
and slow (Y) scanning mirrors, respectively. From these two figures it can be seen that the
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curvature is concave in one case, and convex in the other case, which shows that the back focal
plane of the objective is imaged in between the two scanning mirrors. Figure 12 (C) shows the
en face projection image generated from the mirror. It can be seen that the brightness of the
mirror reflection is highest at the center of the field, which extinguishes when approaching to
the edges of the scan field.
Figure 12: Scan field curvature due to non-telecentric scan of the beam. Images are obtained
by the 1060 nm OCM system using the 40X objective. (A) and (B) show cross sectional images
from two orthogonal directions whereas (C) shows the corresponding enface projection.
Note that, the field curvature depicted in Fig. 12 is particularly deleterious for a TD-OCM
system, as the fixed reference arm delay determines the depth of the image that will be
acquired. Moreover, if a high NA objective needs to be employed in the system in order to
generate simultaneous two-photon or second harmonic generation images, then the confocal
range will also be limited. Therefore, the curvature has to be less than the confocal range and
the confocal and coherence gates matched to each other, in order for the TD-OCM image to be
generated. Hence, one has to limit the field of view to the extend that the curvature in the scan
field is sufficiently small. In a study by Tang et al., featuring multimodal time TD-OCM and
MPM, the FOV was limited to as low as 20 um x 20 um due to this constraint [8].
However, due to major advantage of Fourier domain imaging methods which provide
depth resolved images, one can still recover images from the whole FOV even when the scan
field is curved. For this purpose, one can use either a mirror reflection similar to the one
depicted in Fig. 12, or if the sample is imaged using a cover slip then it would be better use the
reflection from the second surface of the cover slip which is in contact with the tissue. Then,
this image can be used as a reference field for the calibration of the field curvature, which can
be accomplished by circularly shifting individual A-lines according to the distance between the
location of the calibration field for that particular A-line and the location of the calibration at
the center of the image. Hence the procedure for the correction of the scan field curvature
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would be to segment the mirror or the cover slip reflection for each frame, then apply a
smoothing filter or a polynomial fit to construct the three dimensional surface profile. Finally,
this profile is used to circularly shift each individual A-line in the image.
Figure 13: Correction of scan field curvature demonstrated by ex vivo human colon images
obtained by the 1060 nm OCM system using the 40X objective. (A) and (B) are from two
different depths from the same dataset, where (C) is the calibrated image. Dashed lines
indicate the regions that are in focus for that particular depth. Arrows point to goblet cells.
Figure 13 demonstrates an example for the impact of the scan field curvature on the
images generated from ex vivo human colon sample using the 40X Olympus objective. Note
that, in Fig. 13 (A) and (B), which are selected from two different depths of the same dataset
(~40 um apart), different portions of the image are in focus. This can be clearly seen by the
visualization of goblet cells at the regions where the sample in focus. By following the
procedure outlined in the previous paragraph, the image shown in Fig. 13 (C) is generated
which shows uniform resolution throughout the field of view. Notice that the goblet cells are
now visible in both of the regions highlighted in Fig. 13 (A) and (B).
Note that circular shifting of A-lines can be thought as multiplying the A-lines with a linear
phase. Hence, in order to gain computational speed, one can also compensate the dispersion in
this step by integrating the dispersion to the phase that will shift the A-line. This technique of
compensating scan field curvatures while simultaneously compensating for the dispersion has
been demonstrated in several studies [9, 10]. Another point to mention is that, this method
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assumes that the focus will maintain the same curvature when the beam is propagating inside
the sample. However, due to aberrations caused by the scattering inside the sample, the shape
of the curvature might also change when the focus is deep inside the sample. If a high NA
objective is used for imaging, then one can find the actual focal curvature inside the sample as
the cross sectional image will be in the form of a bright stripe corresponding to the focal plane
[11, 12]. In this case a sharpness or maximum intensity metric can be used to segment the
actual focal curvature of the beam inside the sample, and use this as the calibration field.
However, the field curvature can be observed even for the lower power objectives, such as the
1oX and 20X objective where the focal plane can not be estimated precisely from the cross
sectional images. In that case it will be more appropriate to estimate the scan field curvature
from the mirror or cover slip reflection.
ii. Imaging with Low Power Objective and Surface Flattening
Usually a microscope cover slip (with a thickness around 0.16 - 0.2 mm) is used for microscopy
imaging systems in order to ensure a flat imaging surface, as depth variations can be
detrimental if the depth of focus of the objective is very short. For imaging systems such as
multiphoton imaging, confocal imaging and TD-OCT, this is especially important as imaging is
limited to the very superficial layers or, for the case of TD-OCT, the reference arm length must
be matched to the confocal range.
When a low power objective with a long depth of focus is used for imaging, such as the
1oX Zeiss objective employed in this study, on other hand, the use of cover slip can cause some
undesired artifacts, as the reflection from the surfaces of the cover slips can overwhelm the
signal originating from the sample by increasing the noise floor of the fringes. An example for
this phenomenon is given in Fig. 14. Figure 14 (A) demonstrates a cross sectional image of an ex
vivo human colon sample taken with a 10X objective using a cover slip. The focus is set about 60
um below the second surface of the cover slip and the depth of focus is calculated to be about
50 um for this configuration. There is a bright reflection from the second surface of the cover
slip which also produces the horizontal bright lines seen in the image. A zoomed view around
this region is shown if Fig. 14 (B), where these horizontal artifact lines can be observed upto 100
- 150 um below the second reflecting surface of the cover slip. Figure 14 (C) shows the en face
reconstruction below ~40 um of the second surface of the cover slip, where the brightness
caused by the reflection from the cover slip overwhelms the actual image. Figure 14 (D), on the
other hand, is taken about ~60 um below the second surface and the crypt structure of the
colon can still be discerned. Hence, it can be inferred that when imaging is performed with a
low NA objective, cover slip causes imaging artifacts due to high reflections from its surfaces,
upto an imaging depth which is related to the depth of focus of the imaging configuration.
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On the other hand, the relatively high depth of focus of the low power objective makes it
less critical for the imaging to be performed on a flat field; hence the use of a cover slip might
not be necessary for this case. However, if the sample is tilted too much or has some
topographical properties, such as protrusions or dips, then one can see structural variations
along the en face imaging plane. This is demonstrated in Fig. 15, taken from a fixed ex vivo
human colon sample using the 1oX objective, without the usage of cover slip. Especially in Fig.
15 (B), one can appreciate the degree of tilt that is present in the image. The en face
reconstruction in Fig. 15 (C) clearly shows the variations on the structural features along the
image. The beginning portion of the image shows superficial layers whereas towards the end,
the imaging plane gets deeper and one can see the crypt architecture.
Figure 14: Cross sectional (A,B) and en face images (C,D) of an ex vivo colon sample taken with
a 1oX objective using a cover slip. (C) is from ~40 um below the second surface of the cover
slip, whereas (D) is from ~60 um below that surface. Green arrows in (B) point to some of the
horizontal artifacts caused by the reflection from the second surface of the cover slip. Images
are taken using the 1310 nm 0CM system.
A straightforward method to compensate for the topographical variations seen in Fig. 15
is to detect the surface of the specimens from cross sectional images, then shift the images of
the individual A-lines according to its distance from a pre-determined center, which will ensure
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a flat surface. A similar procedure outlined in the previous endoscopic OCT studies is followed
to accomplish this task [13]. This algorithm operates on each cross sectional image to segment
its surface. Briefly, a gaussian and median filter is applied to the frames in order to reduce the
speckle noise. Then, the frames are thresholded in order to remove the noise especially above
the surface portion of the image. Note that a relatively high threshold can be chosen here as
the reflection from the surface is expected to be quite high. Afterwards, a Canny filter is applied
that detect the edges in the image. Surface then can be detected by finding the first non zero
elements in each A-line. The final step is to apply another median filter to the array of edge
locations for that individual frame, in order to remove outliers in the detected edge and ensure
a smooth surface profile. Once the surfaces are detected on each cross sectional frame, one
can circularly shift the A-lines according to the distance between the location of the detected
surface of that A-line and a pre-determined center depth, similar to the correction of the scan
field curvature described in the previous section. Using this method a flat surface will be
ensured at that pre-determined center.
Figure 15: Imaging without using the cover slip using the low power (10X Zeiss) objective.
Cross sectional images from XZ (A) and YZ (B) directions and en face reconstruction (C) along
the depth shown by the dashed line. Images are taken using the 1310 nm 0CM system.
Figure 16 shows the cross sectional and en face images after the surface flattening
algorithm is performed. Comparing Fig. 16 (B) to Fig. 15 (B) one can appreciate the success of
the flattening in the cross sectional image. Moreover, as can be seen from the en face
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reconstruction depicted in Fig. 16 (C) and Fig. 16 (D), which are selected from two different
depths, uniform structural information is present throughout the image, as opposed to Fig. 15
(C), where the two features seen in these images are mixed along the imaging plane. Notice
that although surface can be flattened in post processing, the degree of tilt still should be small
enough such that the features of interest remain inside the focal range for the cross sectional
images. Hence the utility of this approach will be limited for low power objectives with a large
depth of field, or for the samples that have limited tilt or topographical variations.
Figure 16: Cross sectional (A,B) and en face (C,D) images after surface is flattened. Dashed
lines in the cross sectional images indicate the location selected for the en face plane. Images
are taken using the 1310 nm 0CM system.
iii. Color Maps for en face Display
The final step in the SS-OCM processing is to select several depths of interest from the
volumetric dataset, and then to construct and display the en face images corresponding to the
selected depths. Traditionally OCT images are displayed in a logarithmic scale, where the
logarithm of the intensity images are taken and scaled to a bit depth of 16 bits after applying a
threshold to crop the noise level and high intensity reflections. Taking the logarithm essentially
compresses the dynamic range of the intensity image, which is necessary for cross sectional
OCT images as there is a large variation of the signal intensity across different depths of the
image. However, for en face images that corresponds to a specific depth, the signal variation is
not as high as it is in the cross sectional images. Therefore, logarithmic compression might be
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an overshoot for displaying OCM images. The uncompressed images, on the other hand, might
still have too much intensity variation across the image where high intensity areas might appear
as saturated and obstruct the delineation of fine structures. Consequently, a square root
compression is considered as a good trade off for the display of OCM images, which balances
the intensity saturation and the visualization of fine details in the images [14].
Another consideration for the visualization of the OCM images is the selection of a
suitable color map. OCT and OCM imaging has single contrast generating channel (intensity
image), which suits the usage of a single color display such as grayscale. Direct conversion of
the images to grayscale dictates that the areas with high intensity appear as white, whereas the
areas with low intensity appear with the tones of gray and black. This convention is commonly
used in displaying confocal images, which has a similar contrast mechanism as OCM. However,
in some of the OCM studies a negative color scale is chosen instead, in which the regions with
high intensity appear with dark colors [15-17]. This display has the property that the areas with
low signal are white, which gives a closer appearance to standard histology, hemalum and eosin
(H&E) images, and therefore, might facilitate for a pathologist to interpret the images.
Another choice for display is the use of pseudocolor maps. Especially in the field of
ultrasonography the use of false colors as opposed to grayscale display has been shown to
increase the sensitivity and specifity of the radiological readings [18, 19]. Therefore, some of
the commercial OCT imaging devices uses similar pseudocolor display conventions. Pseudocolor
maps can be chosen either single color, or alternatively a range of colors can be used to divide
the color scale. Recently, several confocal imaging studies have employed this approach to
convert grayscale images into RGB colors which mimics H&E color scale [20, 21]. Note that in
the H&E stain used in conventional histology, hemalum colors the nucleus of the cell in varying
shades of blue depending on the concentration and composition the of nuclear material inside
the cell. The second component eosin, on the other hand, colors cytoplasmic structures in
various shades of red, pink and orange. These cytoplasmic structures include cytoplasm of
individual the cells as well as the surrounding connective tissues and other extracellular
substances. Consequently in these confocal imaging studies, an external contrast agent,
acridine orange, has been used which bonds to the nuclear content inside the cells, generating
fluorescence signal originating from the nuclei of the cells [20, 21]. Reflectance confocal or
fluorescence images arising from fluorescein, on the other hand, highlight extracellular space
and show nuclei as dark spots. These two different contrast channels then converted into a
color scale such that the image showing acridine contrast appears in the shades of blue and the
standard confocal image appears in the shades of pink and red.
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cFigure 17: Illustration of regular grayscale color map (A), inverse color scale (B), false color
sepia color map (C), and false color H&E mimicking color map (D) on the images of ex vivo
fresh rabbit kidney specimen. Arrows point to areas showing cellular structures. Imaging is
performed with the 1060 nm OCM system using the 40X Olympus objective.
Figure 17 illustrates some of the color scale concepts discussed in this section. Ex vivo
images taken from renal medulla of a rabbit has been chosen which have well defined cellular
features as pointed by the arrows in the images. When comparing Fig. 17 (A) and~(B), it can be
observed that the cellular features can be selected more easily from the inverse color scale
image, whereas the overall shape of the collecting tubules are more easily discerned in the
regular grayscale color map. Fig. 17 (C) displays a sepia color map which is typically used in
ultrasound images. Finally Fig. 17 (D) displays a false color H&E color map. Note that, as
opposed to the confocal imaging studies discussed previously, OCT does not have a dual
channel contrast mechanism separating nuclei from extracellular substances. However, it has
been suggested that the back scattering from nuclei of the cells dominates the back scattered
signal [22]. Therefore, as done in Fig. 17 (D), by assigning the values of high intensity to the
tones of blue and the values of lower intensity to the tones of red and pink, it might be also
possible to enhance the nuclear contrast in the OCM images.
To summarize, in this section it has been seen that there are many possible choices of
color scales that can be used to display en face OCM images. For majority of the images
included in this thesis standard grayscale color map has been applied without loss of generality.
However, the choice of color scale for a clinical scenario will be application dependent. For
certain OCT applications, such as endoscopic or cardiovascular imaging the choice of sepia color
map can be justified as the competitive imaging modality, ultrasound, has been used for a
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longer time, and the radiologists or endoscopists might have more intuition in reading images
with this color map. For OCM applications, on the other hand, grayscale color map might be a
suitable choice especially for the applications that are in competition with confocal imaging.
The false H&E color scale can also be appealing to pathologist as it resembles to histology more
closely. However, it should be noted that not all applications will have clear nuclear structures
as the images as shown in Fig. 17. For lower GI or breast images that will be shown later in
Section 5.1., nuclear details are not as easily discernible. Therefore, the utility of this color map
for those applications is not clear. As done by the ultrasound imaging studies, the ultimate test
for choosing the optimum color map would be to perform blinded readings for images with
different color maps and selecting the color map that has the highest diagnostic accuracy [19].
4.9. System Characterization
This section will summarize several parameters that have been measured to assess the
performance of the OCM setup, for both the 1060 nm and the 1310 nm VCSEL OCM systems.
The 1060 nm VCSEL system operated at a 100 kHz A-scan rate and give an output light
centered around 1060 nm with 80 nm tuning range. The output power of the light source is ~15
mW, whereas the collimated power in the sample arm is around 8.6 mW. The power onto
sample is around 3.1 mW with the 40X Olympus objective, causing a total throughput of 36%
for the sample arm. Note that, as previously mentioned, the low efficiency of the objectives
around IR wavelengths is the main cause for the low throughput of the system. As for the 1310
nm VCSEL system, the operating frequency is set to 280 kHz, which causes an effective A-scan
rate of 560 kHz. The output light is centered around 1310 nm, with a full tuning range of 120
nm. The output power of the laser is around 30 mW, and the collimated power on the sample
arm is around 14.7 mW. The power onto sample is around 5 mW with the 40X Olympus
objective, causing a throughput of 35%. The throughput with the Zeiss objectives is about 45%.
The axial resolution for the 1060 nm system is measured to be around 12.9 um when the
full tuning range was used. However, for this configuration the system is not working stable
probably because the lower ends of the sweep range is causing triggering issues. Hence the
tuning range is decreased in the software and an axial resolution of 13.6 um is used for the
imaging. For the optically clocked 1310 nm VCSEL system the axial resolution is measured as
11.4 um, when the full tuning range was used. Figure 18 (A) shows the PSFs of the original
spectrum. Note that in order to numerically compensate the dispersion, spectrum is multiplied
by the inverse of its phase, as described in Section 4.6. Note that due to the sharp edges of the
VCSEL spectrum, the sidelobes of the PSFs are relatively high. In order to reduce the sidelobes,
a smoothing window can be applied to the spectrums. Figure 18 shows the PSFs resulting from
three different choices of windows. Note that the improvement in the side lobes comes with a
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Figure 18: Axial PSFs of 1310 nm VCSEL OCM system. Original PSF (A), and PSFs from the
spectrums that are reshaped using a Kaiser window (B), broad Gaussian window (C) and
narrow Gaussian window (D). Axial resolutions are measured as 11.4 um, 12.5 um, 13.1 um
and 14 um for (A-D), respectively. Resolution values are in air.
penalty on the axial resolution. For the majority of the images shown in this thesis either no
window is applied to the spectrums or a broad Gaussian window is applied which caused < 1
um of loss in the axial resolution. Note that the axial resolution values reported here are
measured in air, hence they need to be divided to a factor of 1.39 - 1.44 in order to convert
them to the resolution values in the tissue. When this conversion is performed, the axial
resolution of the optically clocked 1310 nm system is calculated as 8.14 um.
Figure 19 shows PSFs obtained by translating the reference arm to various depths
throughout the imaging range. The intensity signal is plotted on a logarithmic scale where it is
linearized by the highest intensity among the PSFs. A uniform intensity can be observed
throughout the imaging range of the system proving the long coherence length of the VCSEL
source. Note that, especially for spectral OCT systems a 6 dB drop is usually observed at half of
the imaging range which degrades the image quality at deeper regions of the sample. As a side
note, since the MZI signal employed for optical clocking had a maximum of 400 MHz signal
component, which falls well within the bandwidth of the balanced detector as well as the DAQ
no additional roll-off is observed due to the nonlinearity of these detection devices at higher
frequencies. Hence, if an MZI signal with higher frequency were used to clock the DAQO then a
residual roll-off is expected to occur especially at higher imaging depths.
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Figure 19: PSFs from different depths of the optically clocked 1310 nm system showing
virtually no roll-off for the entire depth range.
The transverse resolution of the system can be characterized by imaging an USAF
resolution chart. Figure 20 displays an image taken by the 40X objective. Note that the smallest
element in the chart is resolved which indicates a transverse resolution better than 2.2 um. In
order to measure the exact transverse resolution a knife edge test can be performed [23]. For
this test, the intensity drop from an edge in the resolution chart is plotted and the width from
90% of the maximum value to 10% of the maximum value is calculated. Then this edge width is
multiplied with 0.78 to calculate the 1/e 2 transverse resolution. Using this test the transverse
resolution is measured as 0.86 um for the 40X Olympus objective. Transverse resolution is also
measured with the 1OX Zeiss objective where the smallest resolvable lines in the resolution
chart predicted a resolution of 3.11 um. Note that these values are consistent with the
theoretical values calculated in Section 4.1.
Finally, the sensitivity of the 1310 nm system is measured as 102 dB. For the
measurement of the sensitivity an ND filter of 3.3 OD is inserted to the sample arm to attenuate
the reflection from a mirror placed to the focus of the objective. The reference arm power is
adjusted to an optimum value until the best sensitivity is achieved. The reference arm signal is
also recorded by blocking the sample arm. The processing consisted of removing the reference
arm signal from the interference fringe followed by the Fourier transform operation. The value
of the resulting peak intensity is divided by the standard deviation of the noise level, then the
logarithm of this ratio is taken and multiplied with 20, which gave a value of 36 dB. Due to the
double pass of the light on the sample arm, the OD value of 3.3 of the ND filter corresponds to
an attenuation of 66 dB. Consequently a sensitivity of 102 dB is measured.
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Figure 20: Image from USAF resolution chart taken by the 40X objective where the smallest
element in the resolution chart is clearly delineated.
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5. Imaging Results
In this chapter, some example images obtained with the 1060 nm and 1310 nm VCSEL OCM
systems will be presented. Unless noted otherwise, majority of the images are displayed after a
square root compression and with the positive grayscale color map. In order to obtain
corresponding images without performing histological processing, some of the specimens are
imaged with a multiphoton microscopy (MPM) imaging system possessed by our group.
Immediately after the OCM imaging session is conducted, specimen is stained with acridine
orange which, as previously mentioned, stains the nuclei of the cells. When it is excited with a
high power laser around 740 nm, it emits a two photon signal around 530 nm. Furthermore,
with the same excitation, second harmonic signal centered at 370 nm is also emitted from
collagen structures that are typically residing in the extracellular spaces of the cells. As a
consequence, the resulting image displays two color channels corresponding to two photon
fluorescence from the nuclei and second harmonic generation from the collagen in the stroma,
similar to the counterstaining role of hemalum and eosin in the standard histological processing
as discussed in Section 4.8 [1].
5.1. Imaging Results with the 1060 nm System
Initial imaging studies have been conducted with the 1060 nm VCSEL OCM system. According to
the imaging protocol, fresh specimens are imaged within a few hours after excision. Prior to
imaging of the specimens, they are dipped into a 6% acetic acid solution for ~1 minute followed
by a ~30 second wash with water, in order to increase the nuclear contrast by the mechanism
which condenses nuclear material in the cell and increases the scattering from the nuclei [2].
Imaging is performed in the modified cassette used in standard histology, as previously
described. The 40X Olympus water immersion objective is employed whose properties are
given in Section 4.1.
Figure 1 show ex vivo OCM images from freshly excised rabbit kidney samples together
with the corresponding MPM images. In Fig. 1 (A) and (B) a glomerulus and surrounding
convoluted tubules can be observed, which are characteristic features of renal cortex. Figure 1
(D) and (E) are also from renal cortex and delineate the contour of the convoluted tubules more
clearly. Figure 1 (C) and (F), on the other hand, show the collecting tubules from renal medulla
where cellular features in the epithelial lining of tubules can be clearly discerned. Figure 1 (G)
and (T) show the corresponding MPM images from renal cortex and medulla, respectively.
These images are acquired by setting the focal plane ~ 50 um deep from the surface of the
specimen.
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Figure 1: OCM and corresponding MPM images from ex vivo fresh rabbit kidney obtained
using the 40X Olympus objective. Specimens are treated with 6% acetic acid. (A, B, D, E, G) are
from renal cortex, whereas (C, F, H) are from renal medulla. Arrows point to cellular features
apparent in the epithelial lining of the tubules. CT: Convoluted tubules, G: Glomerulus, T:
Collecting tubules.
Figure 2 shows ex vivo OCM images from freshly excised rabbit colon sample together
with the corresponding MPM image. In this figure, contour of the colonic architecture can be
identified with occasional crypts. Note that the sizes of the crypts are relatively smaller and
they are not very densely packed compared to the crypts usually observed in human colon.
Furthermore, goblet cells can not be visualized neither in the OCM nor in the MPM images.
Figure 3 shows ex vivo OCM images from freshly excised normal human colon specimen
together with a representative histology. Figure 3 (A-C) have been obtained from the same
imaging location, by translating the focus ~20 um between each acquisition. The depth
dependent features of the crypt architecture can be appreciated in these images. A close
correspondence can be observed between OCM images and the histology image shown in Fig. 3
(F). Note that OCM images clearly delineate the mucin secreting goblet cells residing on the
outer linings of the crypts.
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Figure 2: OCM and corresponding MPM images from ex vivo fresh rabbit colon obtained using
the 40X Olympus objective. Specimens are treated with 6% acetic acid. Arrows point to crypts.
Figure 3: OCM and representative histology from ex vivo fresh human colon obtained using
the 40X Olympus objective. Specimens are treated with 6% acetic acid. (A-C) have been
obtained from the same imaging location, by translating the focus ~20 um between each
acquisition. (D) and (E) are from different imaging locations on the same specimen. Arrows
point to goblet cells.
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Figure 4 shows a mosaic image from freshly excised normal human colon sample obtained
by constructing the mosaic image from 16 overlapping frames, using the methods described in
Section 4.7. The total field is increased to about 1 mm x 1 mm in this representative mosaic
image. From the link provided in the caption the deep zoom formatted image can be accessed,
which allows the user to pan around the image and to zoom to regions of interests, similar to
the Google earth view. As a side note, it is worth noting that from this large FOV mosaic image,
a Type - I pit pattern, which is the characteristic appearance of normal colonic mucosa as
discussed in Section 2.2. can be clearly observed. Therefore, generating large FOV images has
the advantage of identifying the crypt architecture of the colon which will facilitate the
assessment of the neoplastic state of the tissue, while regions of interests can still be
investigated with high resolution.
Figure 4: Large FOV mosaic image from ex vivo fresh human colon obtained by stitching 16
frames. The deep zoom file can be accessed from the following link which allows pan and
zoom the image: http://bit.ly/SPvqVM
Figure 5 shows an example of a large field OCM image from an ex vivo invasive breast
cancer sample, together with a multiphoton image of the same region and representative
histology. The OCM image shown in this figure is generated by combining 96 frames with a field
of 420 um x 420 um each to obtain a 1.8 mm by 2.6 mm total field. Sepia color map is chosen
for displaying the OCM image. Adipose tissue and invasive lesions are distinguishable in the
OCM image as hollow circular structures and homogenous high scattering tissues, respectively.
Residual stroma, identified as parallel stripes in the OCM image is also present and
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Aencapsulates the tumor tissue. Note that, this sample is from a highly invasive breast cancer,
where the delineation of individual nuclei is challenging even in the MPM images. Therefore,
the contrast in the OCM image is relatively low. For a less invasive or normal breast lesion, it
should be possible to identify ducts, lobules and surrounding stroma, which are characteristic
features of the breast tissue.
Figure 5: OCM and multiphoton image of an ex vivo fresh breast cancer sample and
representative histology. OCM image is obtained using the 40 X Olympus objective.
Specimens are treated with 6% acetic acid for the OCM image and acridine orange for the
MPM image. OCM image is constructed by merging 96 frames. (D) shows a zoomed view for
the region shown with dashed lines in (A). IL: Invasive Lesion; SC: Stromal Capsule; S: Residual
Stroma; A: Adipose. The deep zoom file can be accessed from the following link which allows
pan and zoom the image: http://bit.ly/UzbiVz
5.2. Imaging Results with the 1310 nm System
Preliminary images have already been obtained with the 1310 nm VCSEL OCM setup, although
the system is still under development. Similar to the 1060 nm OCM system, imaging is
performed in the modified cassette. The 40X Olympus water immersion objective and 20X Zeiss
objective are employed for the imaging, whose properties are given in Section 4.1.
Figure 6 depicts examples of OCM images of ex vivo fixed human colon samples
obtained with the 1310 nm system. Note that this is the same specimen whose images are
depicted in Fig. 3 and Fig. 4, and the image quality looks comparable to those images, despite
imaging is done on fixed specimens. Figure 6 (C) is taken using the 20X Zeiss objective, and
shows reasonable image quality and minimal loss in resolution compared to the images taken
with the 40X objective. Note that for the 20X image the scan angle of the scanning mirrors are
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adjusted to a smaller value in order to acquire similar FOV as the 40X objective for comparison
purposes, whereas the total FOV with the 20X objective is about 1.25 mm x 1.25 mm as
discussed in Section 4.1.
Figure 6: OCM image obtained from ex vivo fixed human colon sample using the 1310 nm
system. (A,B) are obtained with the 40X objective whereas (C) is obtained with the 20X
objective.
Note that, as discussed previously, the use of lower NA objective with a longer
confocal range enables to exploit the full power of the Fourier domain OCM imaging which
enables the acquisition of multiple imaging depths simultaneously. As a demonstration, Fig.
7 shows OCM images from an ex vivo fixed human colon sample. These images are selected
from the same volumetric dataset, at a depth location 50 um apart from each other. Depth
dependent features of the crypt architecture can be clearly observed in the images. As a
side point, note that the crypt structure seen in Fig. 7 (B) is remarkably different compared
to the crypt structure seen in Fig. 6. This might be due to the different compression that the
modified histology cassette applies to the tissue or the differences in the tilt of the crypts
for the two different samples. Nevertheless, these images show the high impact on the
differences in the sample preparation on the resulting OCM images. Therefore, in order to
be able to obtain consistent images, it is important to use the same protocol (applying same
pressures etc.) for imaging different specimens of the same tissue.
Note that for the OCM images shown in this section, the specimens were fixed for a
few months when they are imaged, which might cause a loss in the contrast due to
degradation and changes in the optical properties of the tissue. Although the colon is
preserved relatively well during fixation, the loss in the contrast for other tissues such as
kidney and breast are very drastic and it is not possible to obtain good quality OCM images
from fixed specimens of those samples. Recruitment of fresh samples of human colon,
kidney, breast and thyroid to be imaged with the 1310 nm system is currently ongoing.
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Figure 7: OCM image obtained from ex vivo fixed human colon sample with the 20X objective.
Images are selected from the same volumetric dataset, 50 um apart from each other in depth.
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6. Summary and Future Work
In summary, in this study a swept source OCM system has been demonstrated which employs a
novel VCSEL light source. The A-scan rate of the OCM system can easily reach > 1 MHz when the
system is run off-resonance and it is shown that optical clocking circumvents the deleterious
effects related to the sweep variations of the VCSEL that run in this mode. The axial resolution
of the system with the 1310 nm light source is measured as 8.1 um in tissue, which is still lower
than time domain and spectral OCM systems. However, next generation VCSELs are expected to
have ~160 nm tuning range which will improve the axial resolution to < 6 um. When the broad
tuning range VCSEL becomes available it will replace the laser currently employed in the OCM
setup.
Recruitment of fresh samples to be imaged with the 1310 nm VCSEL system will continue
in the future. For this purpose a variety of pathologies have been identified which will show the
fidelity of the imaging system. These pathologies include colon (normal, tubular adenoma,
adenocarcinoma), breast (normal, ductal carcinoma in situ (DCIS), invasive ductal carcinoma
(IDC)), kidney (normal and cancer) and thyroid (normal and cancer). Furthermore, modifications
to the imaging setup will continue to be implemented to make it more compact and robust, so
that it can be transported to the pathology laboratory or to the endoscopy suite. Once the
system is placed to the clinic it will be possible to conduct large scale studies for selected
applications that will show the sensitivity and specifity of OCM imaging in making real time
diagnosis. Towards this end, an alternative, inverted microscopy design can be implemented
where the specimen is placed directly on a cover slip and illuminated from the bottom. This will
make the imaging process easier, as well as it will reduce artifacts due to the pressure applied
to the tissues when they are pressed against the cover slip in the modified cassette. An inverted
microscope design, however, will require the use of air immersion objectives, which might
cause issues with increased noise floor due to the reflections from the cover slip surfaces as
seen in Section 4.8. Anti reflection coatings for the cover slips can be employed to overcome
these issues.
Another aspect of real time imaging with a Fourier domain OCM system is the demanding
processing speeds, as one needs to process the full volumetric dataset in order to obtain en
face images. The current acquisition software used in our group is able to process the datasets
with relatively fast speed using parallel processing architectures and is constantly being
improved. However, if processing speeds are proven to be a limiting factor, then alternative
processing strategies, such as direct computation, Goertzel algorithm or zoom FFT algorithms
can be employed that will produce en face images from selected depths with an increased
speed compared to taking the full FFT of the fringes.
With the novel 0CM scanning probes it is possible to translate this imaging modality to an
in vivo setting, where the OCM probe can be inserted through the working channel of the
endoscope and obtain images similar to CLE. Especially for some of the clinical challenges in the
management of lower GI diseases discussed in Chapter 2, OCM has distinct advantages over
CLE which can make this technology a strong alternative to the latter imaging modality. In this
respect, the benchtop OCM system developed in the course of this thesis plays a major role in
determining the quality of the images that can be expected with the endoscopic OCM probe.
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